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Interplay of Extrinsic and Intrinsic Cues in Cell-Fate Decisions
Abstract
A cell’s decision making process is coordinated by dynamic interplay between its extracellular
environment and its intracellular milieu. For example, during stem cell differentiation, fate decisions are
believed to be ultimately controlled by differential expression of lineage-specific transcription factors, but
cytokine receptor signals also play a crucial instructive role in addition to providing permissive
proliferation and survival cues.
Here, we present a minimal computational framework that integrates the intrinsic and extrinsic regulatory
elements implicated in the commitment of hematopoietic progenitor cells to mature red blood cells
(Chapter 2). Our model highlights the importance of bidirectional interactions between cytokine receptors
and transcription factors in conferring properties such as ultrasensitivity and bistability to differentiating
cells. These system-level properties can induce a switch-like characteristic during differentiation and
provide robustness to the mature state. We then experimentally test predictions from this lineage
commitment model in a model system for studying erythropoiesis (Chapter 3). Our experiments show
that hemoglobin synthesis is highly switch-like in response to cytokine and cells undergoing lineage
commitment possess memory of earlier cytokine signals. We show that erythrocyte-specific receptor and
transcription factor are indeed synchronously co-upregulated and the heterogeneity in their expression is
positively correlated during differentiation, confirming the presence of autofeedback and receptormediated positive feedback loops.
To evaluate the possibility of employing this minimal topology as a synthetic “memory module” for cell
engineering applications, we constructed this topology synthetically in Saccharomyces cerevisiae by
integrating Arabidopsis thaliana signaling components with an endogenous yeast pathway (Chapter 4).
Our experiments show that any graded and unimodal signaling pathway can be rationally rewired to
achieve our desired topology and the resulting network immediately attains high ultrasensitivity and
bimodality without tweaking. We further show that this topology can be tuned to regulate system
dynamics such as activation/deactivation kinetics, signal amplitude, switching threshold and sensitivity.
We conclude with a computational study to explore the generality of this interplay between extrinsic and
intrinsic cues in hematopoiesis. We extend our minimal model analysis in Chapter 2 to examine the more
complex fate decisions in bipotent and multipotent progenitors, particularly how these cells can make
robust decisions in the presence of multiple extrinsic cues and intrinsic noise (Chapter 5). Our model
provides support to both the instructive and stochastic theories of commitment: cell fates are ultimately
driven by lineage-specific transcription factors, but cytokine signaling can strongly bias lineage
commitment by regulating these inherently noisy cell-fate decisions with complex, pertinent behaviors
such as ligand-mediated ultrasensitivity and robust multistability. The simulations further suggest that the
kinetics of differentiation to a mature cell state can depend on the starting progenitor state as well as on
the route of commitment that is chosen. Lastly, our model shows good agreement with lineage-specific
receptor expression kinetics from microarray experiments and provides a computational framework that
can integrate both classical and alternative commitment paths in hematopoiesis that have been observed
experimentally.
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ABSTRACT
INTERPLAY OF EXTRINSIC AND INTRINSIC CUES IN
CELL-FATE DECISIONS
Santhosh Palani
Supervisor: Casim A. Sarkar, Ph.D.
A cell’s decision making process is coordinated by dynamic interplay between its extracellular
environment and its intracellular milieu. For example, during stem cell differentiation, fate
decisions are believed to be ultimately controlled by differential expression of lineage-specific
transcription factors, but cytokine receptor signals also play a crucial instructive role in addition
to providing permissive proliferation and survival cues.
Here, we present a minimal computational framework that integrates the intrinsic and
extrinsic regulatory elements implicated in the commitment of hematopoietic progenitor cells to
mature red blood cells (Chapter 2). Our model highlights the importance of bidirectional
interactions between cytokine receptors and transcription factors in conferring properties such as
ultrasensitivity and bistability to differentiating cells. These system-level properties can induce a
switch-like characteristic during differentiation and provide robustness to the mature state. We
then experimentally test predictions from this lineage commitment model in a model system for
studying erythropoiesis (Chapter 3). Our experiments show that hemoglobin synthesis is highly
switch-like in response to cytokine and cells undergoing lineage commitment possess memory of
earlier cytokine signals. We show that erythrocyte-specific receptor and transcription factor are
indeed synchronously co-upregulated and the heterogeneity in their expression is positively
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correlated during differentiation, confirming the presence of autofeedback and receptor-mediated
positive feedback loops.
To evaluate the possibility of employing this minimal topology as a synthetic “memory
module” for cell engineering applications, we constructed this topology synthetically in
Saccharomyces cerevisiae by integrating Arabidopsis thaliana signaling components with an
endogenous yeast pathway (Chapter 4). Our experiments show that any graded and unimodal
signaling pathway can be rationally rewired to achieve our desired topology and the resulting
network immediately attains high ultrasensitivity and bimodality without tweaking. We further
show that this topology can be tuned to regulate system dynamics such as activation/deactivation
kinetics, signal amplitude, switching threshold and sensitivity.
We conclude with a computational study to explore the generality of this interplay between
extrinsic and intrinsic cues in hematopoiesis. We extend our minimal model analysis in Chapter 2
to examine the more complex fate decisions in bipotent and multipotent progenitors, particularly
how these cells can make robust decisions in the presence of multiple extrinsic cues and intrinsic
noise (Chapter 5). Our model provides support to both the instructive and stochastic theories of
commitment: cell fates are ultimately driven by lineage-specific transcription factors, but
cytokine signaling can strongly bias lineage commitment by regulating these inherently noisy
cell-fate decisions with complex, pertinent behaviors such as ligand-mediated ultrasensitivity and
robust multistability. The simulations further suggest that the kinetics of differentiation to a
mature cell state can depend on the starting progenitor state as well as on the route of
commitment that is chosen. Lastly, our model shows good agreement with lineage-specific
receptor expression kinetics from microarray experiments and provides a computational
framework that can integrate both classical and alternative commitment paths in hematopoiesis
that have been observed experimentally.
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Chapter 1
Introduction
‘It’s high time molecular biology became quantitative, it cries out to a physicist… for
modeling. Modeling isn’t a crutch, it’s the opposite; it’s a way of suggesting experiments
to do, to fill gaps in our understanding.’
- John Maddox, Editor of Nature, 1966-73 and 1980-95.

1.1. From genes to behaviors
Biological species show great diversity and exhibit a wide array of complex behaviors.
The displayed behaviors in each species, the phenotype, have been traditionally attributed
to its genetic framework, the genotype. Elucidation of this correlation between genotype
and phenotype is among the most actively studied problems in the biological sciences.
The crux of this challenge lies in the fact that complexity in biological systems is evolved
rather than designed and therefore our knowledge of the underlying framework is
unlikely to be complete. With the advent of molecular biology, the genotype-phenotype
problem was reduced to the understanding of the molecular details of the genetic
elements and their role in exhibiting robust cellular states. The sequencing of the human
genome has led us to uncover most of the molecular elements and classical genetic and
biochemical approaches have successfully revealed most of the cellular states. However,
1

we still lack the mechanistic understanding of how molecular interactions (e.g., proteinprotein or protein-DNA) regulate the processes (e.g., differentiation, proliferation, or
apoptosis) involved in the achievement of cellular phenotypes. It is now well known that
genetic elements are connected through large biochemical networks and their interactions
tend to be highly non-linear. Technological advancement in quantifying gene expression
at the single cell level has led us to identify various biochemical responses that dictate
cellular phenotypes. By studying the network-response dynamics, we can potentially gain
mechanistic insights into cellular behaviors.

1.2. Analytical modeling
Compared to the physical sciences, the role of mathematics in the biological sciences is
far less appreciated. As explained above, non-linearity lies at the heart of biological
problems and studying only the properties of individual molecules or interactions will not
help us in predicting or understanding behaviors. Mathematical modeling and analysis
has traditionally proven potent in understanding non-linear systems and in combination
with classical experiments can provide an invaluable tool in studying biological
processes1.
In the biological community, there is a great deal of skepticism about the utility of
mathematical models in solving complex biological problems. The most popular criticism
among biologist is that any attempt to quantitatively model biological systems is flawed,
as we have not yet identified all of the molecular players or characterized all of the
existing biochemical interactions. This concern is completely valid as we saw from the
2

recent discovery of the previously unknown world of short RNAs2. However, this
limitation only affects those mathematical models that focus on accurately matching
experimental data by exhaustively incorporating from incomplete lists of molecules and
interactions. Even though these models can be closely fitted to data, they often prove less
useful in predicting newer experiments or in uncovering underlying principles if
fundamental mechanisms are missing from the model description.
An alternate modeling approach, which does not suffer from the limitations of
exhaustive modeling is analytical modeling or in a more ideal case, minimal modeling
that targets only the most important players in a given biological process and shows how
topological connections between these molecules may influence the overall property of
the system studied (Figure 1.1). These models, when constructed with reasonable
approximations, tend to be predictive and can identify key processes that regulate the
overlying behavior.

1.3. Cell differentiation
Cell differentiation is a process in which a progenitor cell commits and morphs into a
more lineage-restricted progenitor or a mature cell. This process has been intensely
studied for decades by cell and developmental biologists, therefore making it an attractive
dynamic system to model. As shown in Figure 1.2, studies have characterized several
network topologies and responses that lead to various phenotypic behaviors3. With
respect to cell differentiation, the most well recognized response is the “all-or-none”
switch-like response and the most studied players are the lineage-specific cytokines and
3

transcription factors (this is particularly true in the hematopoietic system, discussed
further in Chapter 2). Lineage-specific cytokines are cell-extrinsic molecules that bind to
their cognate receptors on the cell surface and transmit signals through a cascade to the
nucleus that promotes survival, proliferation and differentiation of the cell to a particular
lineage. Lineage-specific transcription factors are cell-intrinsic, DNA-binding elements
that bind to the promoter elements of the lineage-specific gene and regulate their
expression. A primary focus of this dissertation is to examine how known topological
connections between cell-extrinsic cues (e.g., cytokines) and cell-intrinsic factors (e.g.,
transcription factors) can give rise to all-or-none switch-like responses during
differentiation.

1.4. All-or-none response
Cell differentiation was originally thought to be a process in which an undifferentiated
cell gradually transitions into a mature state by traversing through a series of stable
intermediate states. This theory originated when cell differentiation was studied with
classical population averaging experiments like western blotting or RT-PCR. As seen in
Figure 1.3A, when undifferentiated cells are treated with various levels of differentiationinducing stimulus and the population average of a lineage-specific gene is measured, the
experiment shows a graded response, i.e., the expression of the lineage-specific gene
increased linearly with stimulus concentration. This effect can be explained by the
proposed theory that each cell rests on a stable intermediate state based on the
concentration of the stimuli (Figure 1.3B). However, with the advent of single cell
4

measurements, when the same experiment was repeated, it was noticed that the cells do
not navigate through stable intermediate states, whereas the percentage of cells resting in
the initial state and final differentiated state changes with the concentration of the stimuli
(Figure 1.3C). According to this observation, each cell either remains in the
undifferentiated state or differentiates completely to the mature state, hence the name allor-none or bistable response4-8.

1.5. Significance of a bistable response
There can be several physiologically significant advantages in possessing a bistable
response instead of a graded response during cell differentiation. Figure 1.4 shows the
steady-state expression of a lineage-specific gene to varying concentration of stimulus for
a graded and a bistable response. By comparing the plots, we can see that the bistable
response is less noisy and requires a threshold concentration of stimulus to exhibit a
strong expression. Also, the off-state and on-state, classified based on the expression of
the gene, are discrete in a bistable response. Moreover, the high-expression on-state
achieved in the bistable response is much more robust to fluctuations in stimulus
concentration than graded response due to the presence of hysteresis or memory
(discussed further in Chapter 2).

5

1.6. Positive feedback loops in cell differentiation
It is not that apparent how the graded response curve arising from cytokine-receptor
binding can give rise to an all-or-none response during cell differentiation. The answer
may lie in the non-linear wiring of the signaling topology that transmits information into
and out of the cell. Networks associated with cell differentiation that are capable of
exhibiting bistable response most often require positive feedback loops for achieving
non-linearity. Figure 1.5 shows examples of minimal topologies that exhibit different
responses. Let us consider S as the stimulus and A as a transcription factor that activates
a series of lineage-specific genes B, C, and D. If S activates A linearly and A
correspondingly activates B, C and D, the system shows a graded response (Figure 1.5A).
When an auto-activation loop is added to the first topology, the system shows an
ultrasensitive response (Figure 1.5B). Ultrasensitivity is a system level property in which
a less-than 81-fold increase in stimulus drives the system form 10% to 90% response9.
Since the transition curvature is steeper in an ultrasensitive network compared to a graded
network, they tend to be less noisy; however, they do not possess hysteresis or memory
of the stimulus. When the auto-activation loop requires cooperative binding of the
transcription factor A, the system shows bistability (Figure 1.5C). Transcription
autofeedback loops with cooperativity are indeed the most recognized topology for
showing all-or-none response during cell-differentiation10.

6

1.7. Significance of the research
Throughout the normal lifespan of an organism, certain cells and tissues require adult
stem cells for turnover and repair. Adult stem cells provide an excellent alternative to
embryonic stem cells in basic research and clinical treatment. Also, using adult stem cells
for research and clinical purposes avoids any ethical or legal issues that are associated
with embryonic stem cells. However, the number of cell types that can be generated by
multipotent adult stem cells compares poorly with pluripotent embryonic stem cells.
Studies of adult stem cells can provide valuable information about complex signaling
events occurring during tissue maintenance and repair. One of the most important
motivations in these studies is understanding how undifferentiated cells differentiate and
stay differentiated. Dysregulated cell division and differentiation can lead to various
physiological disorders including various forms of cancer and tissue abnormalities.
Understanding the molecular details of cell cycle progression and stem cell
differentiation can suggest new therapies for such diseases.
One of the most important potential applications of adult stem cells is cell-based
therapies. The need for transplantable organs and tissues far surpasses the available
supply. Stem cells directed to differentiate into specific cell types can offer an everlasting source of replacement cells and tissues to treat diseases including anemia,
leukopenia, thrombocytopenia, Type I diabetes, Parkinson’s, Alzheimer’s, spinal cord
injury, heart disease, stroke, arthritis, burns and immunodeficiency diseases. For
example, in anemia and thrombocytopenia, patients have lower-than-normal blood counts
7

of erythrocytes and platelets, respectively. Directed differentiation of stem cells to
produce erythrocytes and megakaryocytes can provide potential therapies through
autologous or allogeneic transplants.
It is well appreciated that understanding and manipulating cellular function
requires much more than identifying cellular components and establishing componentcomponent interactions. There is a constant need to understand how these components
work together to produce complex, often emergent, behaviors. Systems biology has been
successfully used to study biological pathways and its interactions as non-linear
networks. Mathematical modeling of these networks can help us gain a quantitative and
predictive understanding of a biological system and can further assist in establishing the
core topologies that can be used to re-wire or re-engineer native pathways to attain
desired phenotypes. Systems biology can thus provide a design framework within which
synthetic biology can operate. Synthetic biology is still an emerging field, which has
great potential to contribute to a wide-range of applications from therapeutics to alternate
fuels. Synthetic biologists are currently at the stage of constructing and testing out
fundamental motifs, which can provide a wide range of complex behaviors including
ultrasensitivity, bistability, hysteresis, oscillations, noise-reduction and logic gates. In the
near future, these regulatory modules can be interfaced with various sensory inputs
(environmental, physical or chemical) to confer desired, complex biological responses in
processes ranging from metabolism to protein synthesis to cell differentiation.
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1.8. Thesis statement
We will use experimental and computational techniques to understand how
integrating

cell-extrinsic

and

cell-intrinsic

elements

can

regulate

lineage

commitment during cell differentiation and can also be used to create tunable
synthetic molecular switches for cell engineering applications.

1.9. Chapter layout
In Chapter 2, we present a deterministic model of a cytokine signaling pathway that plays
a role in committing progenitor cells to red blood cells, the differentiation process known
as erythropoiesis. This model connects erythropoietin (Epo), an erythrocyte-specific
cytokine and GATA1, an erythrocyte-specific transcription factor. We show that, due to
the presence of multiple topological connections between the cytokine receptor and
transcription factor, the system can exhibit a bistable response to the cytokine even
without cooperativity. Furthermore, we identify a minimal topology within this
erythrocyte model that still gives rise to an all-or-none response. In Chapter 3, we
experimentally demonstrate a positive correlation between EpoR and GATA1 expression
during human progenitor cell differentiation and we explore the dynamics and phenotypic
consequences of this correlation. In Chapter 4, to assess the possibility of using the
minimal model discovered in Chapter 1 as a tunable bistable switch, we construct it
synthetically in Saccharomyces cerevisiae using signaling elements from Arabidopsis
9

thaliana. We demonstrate that key features of our synthetic switch can be rationally tuned
using predictions from our minimal model. In Chapter 5, we extend the minimal model in
Chapter 1 to a multilineage commitment model and provide a stochastic framework for
understanding both canonical and alternative pathways of lineage commitment in
hematopoiesis.

10

Figure 1.1

Figure 1-1 Topology of an autofeedback loop
Stimulus S binds to the response element present upstream of gene A and initiates its
transcription. Once expressed, A can regulate its own expression through an autofeedback loop.
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Figure 1.2

Figure 1-2 List of well studied network topologies and responses
Mechanistic understanding of genotype-phenotype association can be achieved by studying the
underlying network-response dynamics.

12

Figure 1.3

Figure 1-3 Graded vs bistable response in cell differentiation
(A) Western blot showing linear increase in the population-average expression of a gene of
interest with change in concentration of stimulus. (B) Two different models explaining the
observed result in A; graded response (left) and bistable response (right)
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Figure 1.4

Figure 1-4 Steady-state plots for graded and bistable responses
For each stimulus concentration, the system is allowed to reach steady state and the
corresponding response or expression value is plotted. (A) Graded response shows linear change
in the levels of response with increase in stimulus until the system reaches saturation. (B) Bistable
response stays low for stimulus concentrations less the threshold concentration. Above threshold
level, the system switches to the high-expression or on-state. Once the on-state is reached, the
system can sustain the response, even when the stimulus is lowered from the initial threshold
concentration due to hysteresis (dotted red line).

14

Figure 1.5

Figure 1-5 Topologies that give rise to graded, ultrasensitive and bistable responses
(A) Stimulus S activates a transcription factor A, which in turn activates several downstream
genes (graded response). (B) Topology A with an additional transcriptional autofeedback loop
(ultrasensitive response). (C) Topology B with cooperative binding of transcription factor
(bistable response).

15

1.10. References
1.
2.
3.

4.
5.

6.

7.
8.
9.

10.

Callard, R.E. & Yates, A.J. Immunology and mathematics: crossing the divide.
Immunology 115, 21-33 (2005).
Ghildiyal, M. & Zamore, P. Small silencing RNAs: an expanding universe. Nat
Rev Genet 10, 94-108 (2009).
Santos, S., Verveer, P. & Bastiaens, P. Growth factor-induced MAPK network
topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 9, 324330 (2007).
Bagowski, C.P. & Ferrell, J.E., Jr. Bistability in the JNK cascade. Current biology
: CB 11, 1176-1182 (2001).
Becskei, A., Seraphin, B. & Serrano, L. Positive feedback in eukaryotic gene
networks: cell differentiation by graded to binary response conversion. The
EMBO journal 20, 2528-2535 (2001).
Ozbudak, E.M., Thattai, M., Lim, H.N., Shraiman, B.I. & Van Oudenaarden, A.
Multistability in the lactose utilization network of Escherichia coli. Nature 427,
737-740 (2004).
Gardner, T.S., Cantor, C.R. & Collins, J.J. Construction of a genetic toggle switch
in Escherichia coli. Nature 403, 339-342 (2000).
Xiong, W. & Ferrell, J.E., Jr. A positive-feedback-based bistable 'memory
module' that governs a cell fate decision. Nature 426, 460-465 (2003).
Huang, C.Y. & Ferrell, J.E., Jr. Ultrasensitivity in the mitogen-activated protein
kinase cascade. Proceedings of the National Academy of Sciences of the United
States of America 93, 10078-10083 (1996).
Ferrell, J.E. & Xiong, W. Bistability in cell signaling: How to make continuous
processes discontinuous, and reversible processes irreversible. Chaos 11, 227-236
(2001).

16

Chapter 2
Receptor Feedback Loop Can Generate Bistability in GATA-1
Expression
(Adapted from Palani S. and Sarkar C.A. (2008) Positive Receptor Feedback during
Lineage Commitment Can Generate Ultrasensitivity to Ligand and Confer Robustness to
a Bistable Switch, Biophysical Journal, Volume 95, Issue 4, 1575-1589)

2.1. Introduction
The process of cellular differentiation entails a complex series of events through which
an uncommitted progenitor can morph into a stable specialized cell. While many of the
critical individual molecular components involved in specific differentiation processes
have been identified, the complex interactions and topology of signaling and
transcriptional networks can lead to non-intuitive behavior. Mathematical modeling and
analysis can provide insights into the system-level properties that arise from such an
array of interactions.
In cellular processes in which a binary decision must be made, bistability can be
an important system-level property that arises from the corresponding signaling
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networks. Changes in the system input can toggle a bistable system between two steady
states; additionally, the system can display memory by sustaining a high (or low) steadystate response after significant reduction (or increase) in the magnitude of the stimulus1.
Biological examples of bistability include cell-cycle regulation in Xenopus oocytes2 and
Saccharomyces cerevisiae3, self-sustaining biochemical memory4, synthetic genetic
switches5-9, and differentiation of common myeloid precursors into macrophages and
neutrophils10. Bistability is often accompanied by ultrasensitivity to a stimulus, another
common property of nonlinear systems11-13. Since, there is growing evidence that cell
differentiation is an all-or-none ‘switch-like’ event, rather than a continuous transition of
an unspecialized cell into a mature one2, 14, mathematical modeling of the commitment
process is attractive because the switch-like response and cellular memory implicit in the
biological process arise naturally in the formulation of such nonlinear models.
Hematopoiesis, the formation of blood cells, takes place in two distinct stages:
primitive differentiation and terminal differentiation. During primitive differentiation, a
hematopoietic stem cell differentiates into a multipotent or bipotent progenitor cell,
which, upon terminal differentiation, gives rise to a mature cell. Lineage-specific
cytokines (extrinsic) and transcription factors (intrinsic) are believed to be the important
molecular components that affect cell survival, proliferation, and commitment during
terminal differentiation15, 16.
Erythropoietin (Epo) is a hematopoietic cytokine responsible for the proliferation,
survival, and differentiation of erythroid cells17. The Epo receptor (EpoR) has a single
transmembrane domain, an extracellular domain for Epo binding, and an intracellular
domain for signaling18. In the absence of ligand, Epo receptors exist predominantly as
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inactive homodimers on the cell surface19. Binding of Epo to the receptor homodimer
changes the orientation of the receptor subunits, which leads to activation of several
signaling cascades including the PI3K/AKT, STAT5-BclXL, and Ras/MAPK pathways20.
Erythroid progenitors lacking functional EpoR do not mature into erythrocytes and show
phenotypic abnormalities21, 22.
The zinc-finger GATA-1 is a transcription factor that plays a critical role in
erythroid differentiation23,
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. It binds as a monomer to the consensus sequence

(A/T)GATA(A/G), which is present in the promoter and enhancer regions of virtually all
erythroid-specific genes25-28. GATA-1 undergoes several post-translational modifications
(acetylation, phosphorylation, sumoylation, and ubiquitination) that may be critical for its
optimal transcriptional activity29. Analysis of the promoter regions of the EpoR gene
shows no TATA or CAAT box, but does reveal the presence of a GATA-1 binding motif,
thus providing a meaningful link between a lineage-specific transcription factor and a
lineage-restricted receptor30-32. Active GATA-1 also binds to the regulatory region of its
own gene, thereby enhancing its total expression through a positive feedback loop33-36.
Disruption of the GATA-1 gene in murine embryonic stem cells by homologous
recombination blocks erythroid development, emphasizing the absolute need for GATA-1
in red blood cell maturation37.
Common myeloid progenitors give rise to erythroid burst-forming units (BFU-E),
the earliest known erythroid precursor cells. BFU-E mature into erythroid colonyforming units (CFU-E); this is accompanied by an increase in EpoR expression and the
cells become increasingly dependent on Epo38, 39. EpoR and GATA-1 levels both rise in
parallel and reach their maximum during CFU-E maturation into proerythroblasts and
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their subsequent differentiation into early basophilic erythroblasts40, 41. Both GATA-1 and
EpoR levels fall during further maturation from the basophilic stage to the polychromatic
stage as cells synthesize large amounts of globins38,

41

. Further differentiation from

polychromatic erythrocytes to reticulocytes is independent of EpoR and GATA-1, as their
levels fall sharply and the cells also show a decrease in globin expression. Hence, it is
during the temporal window from an early CFU-E to a basophilic erythroblast that EpoR
and GATA-1 may act in concert to drive commitment of the erythroid precursor to
terminal differentiation and induce the synthesis of globins.
Recent evidence suggests several modes of crosstalk between EpoR signaling and
GATA-1 transcriptional activity, and analysis of these interactions may offer insights into
the commitment program during erythroid differentiation. In brief, EpoR signaling via
AKT can lead to GATA-1 activation; in return, active GATA-1 can upregulate synthesis
of both itself and EpoR. Epo activates AKT by phosphorylating this kinase at Ser-473 in
a PI3K-dependent manner42. The importance of AKT signaling in erythropoiesis was
demonstrated in JAK2-deficient fetal liver progenitor cells: erythroid differentiation can
be supported in these cells by overexpressing active AKT and it can also be inhibited by
downmodulating AKT using RNA interference43. Active AKT appears to have a
significant role in enhancing GATA-1 transcriptional activity by mediating some of its
post-translational modifications, including phosphorylation and acetylation. AKT
phosphorylates GATA-1 at Ser-310 and enhances its transcriptional activity in primary
fetal liver cells42. However, mice with a S310A mutation in GATA-1 showed no
hematopoietic abnormalities during normal or stress erythropoiesis, indicating that
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phosphorylation of GATA-1 is dispensable for red blood cell differentiation and may
only be required for maximal activity44.
p300 and CBP acetyltransferases (AT) acetylate GATA-1 at lysine residues
present in the C-terminal tail of its zinc fingers45-47. In vivo ChIP assays show that lysine
to alanine mutations at the acetylation residues dramatically impair GATA-1 association
with chromatin48, suggesting that acetylation is critical for GATA-1-mediated gene
expression. p300 and CBP also have histone acetyltransferase (HAT) activity and may
play a role in enhanceosome stability by acetylating GATA-1 and histones49, 50. AKT
phosphorylates p300 at Ser-1834 and this has been shown to be essential for AT, HAT,
and transcriptional activity of p30051-53. Interestingly, Ser-1834 lies in the E1A binding
domain that is necessary for binding of p300/CBP to GATA-1. It has also been suggested
that phosphorylation may aid in GATA-1 binding to CBP, since the Ser-310 residue of
GATA-1 is within the C-terminal acetylation motif of GATA-1. Taken together, these
results suggest an additional role for Epo (other than providing survival and proliferation
cues) in erythroid precursor commitment and differentiation by activating GATA-1
through the PI3K/AKT pathway and influencing the intrinsic signals that lead to
commitment and differentiation.
Based on this experimental evidence, we present a deterministic model of the
upregulation and activation of the erythrocyte-specific transcription factor GATA-1, a
‘master regulator’ of erythrocyte commitment. Lineage specification models previously
reported suggest that erythrocyte differentiation from erythroid/myeloid bipotent
precursor can arise due to the differential expression of antagonistic transcription factors
(upregulation of GATA-1 and downregulation of PU.1) driven primarily by cell-intrinsic
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events54, 55. These models provide insight into the dynamics of a binary cell-fate decision
from the viewpoint of ‘multilineage priming,’ auto-stimulation, and reciprocal repression.
The present work focuses on erythrocyte commitment rather than differentiation
and examines how both intracellular and extracellular factors may influence the cell-fate
decision. As depicted in Figure 2.1, the topology of our model captures the essential
elements of outside-in signaling (Epo-mediated activation of GATA-1), intracellular
signal amplification (GATA-1-mediated upregulation of GATA-1 synthesis), and insideout signaling (GATA-1-mediated upregulation of EpoR). Using this model, we show that
upregulation of EpoR in erythroid precursor cells upon Epo addition can generate
ultrasensitivity to ligand as well as robust bistability in GATA-1 expression during
commitment and this may provide ‘switch-like’ differentiation characteristics.
Further analysis of a generalized minimal model confirms that the topological
connectivity of the two feedback loops alone is both necessary and sufficient for
generating the overall system dynamics. Although there are several ways of achieving
bistability1, 56, feedback loops are the most commonly identified mechanism; however,
feedback loops that give rise to robust bistability in purely deterministic models have, to
date, been shown to be highly cooperative in at least one reaction57-60. Here, we present a
novel way of achieving robust bistability in cell signaling networks without molecular
cooperativity through two linked positive feedback loops. This topology may have
general implications for cellular decision-making.
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2.2. Model Development
2.2.1. Model construction and description
The core reaction of the proposed erythrocyte commitment model is the activation of
GATA-1 by AKT through EpoR signaling (Figure 2.1; light gray background). Our
model concentrates exclusively on the two positive feedback loops that serve to increase
the concentrations of the reactant species (AKTpp and GATA-1) in this core reaction,
which leads to greater accumulation of GATA-1*, the activated form of a ‘master
regulator’ of erythrocyte-specific genes. The model specifically incorporates the
following components/motifs in the feedback loops which may have an effect on the
overall system behavior. 1) EpoR homodimerization: Unlike many other cytokinereceptor systems, EpoR homodimerizes (but does not signal) before Epo addition, which
should therefore confer ultrasensitivity to the number of receptor dimers available to bind
Epo. This effect was modeled as a two-step process of EpoR binding to JAK2 and EpoRJ
dimerizing to form EpoRJD. Alternatively, EpoR homodimerization could be treated as a
single-step process without considering the effect of JAK2. 2) PI3K/AKT pathway:
Signaling in the MAPK cascade has been shown to convert graded signals into
ultrasensitive responses61; therefore, the similar cascade structure in the PI3K/AKT
pathway might ultrasensitize the signals from the cell surface to GATA-1. 3) Double
phosphorylation of AKT: Recent reports have shown that bistability in signaling circuits
can arise from multisite phosphorylation56; hence, we explicitly modeled AKT activation
as two phosphorylation steps. 4) Transcription and translation: Delay in feedback loops
have been shown to generate interesting behaviors in signaling networks62, so these two
processes were modeled as separate steps. Additionally, explicit inclusion of mRNA
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species in the model facilitates comparisons with experimental microarray data (see
Figure 2.2). The construction of the full model therefore included the following reaction
steps in Figure 2.1.
We have used a deterministic, ODE-based approach to model this signal
transduction/transcriptional network. While this modeling framework represents an ideal
approximation of the true intracellular milieu63, it can still provide useful information
regarding the system dynamics, particularly for nonlinear systems of the type studied
here64. In step 1, JAK2 binds to the intracellular domain of EpoR to form a receptor-JAK
complex (EpoRJ). EpoRJ dimerizes to form EpoRJD in step 3. EpoRJ and EpoRJD
undergo constitutive receptor endocytosis (steps 2 and 4). In step 5, Epo binds to the
extracellular domain of EpoRJD forming the activated complex (EpoRJD*) and the
endocytosis of the complex is shown in step 6. PI3K is activated (PI3K*) by the complex
and is deactivated by a phosphatase (steps 7 and 8). PI3K* converts PIP2 to PIP3 in step
9. PIP3 binds to the PH domain of AKT and phosphorylates AKT on Ser-473 and Thr308 (steps 11-15). This doubly phosphorylated form of AKT (AKTpp) catalyzes the
activation of GATA-1 (step 16). Activated GATA-1 (GATA-1*) is deactivated and
degraded in steps 17 and 26, respectively. Monomeric GATA-1* enhances transcriptional
synthesis

of

nuclear

EpoR

mRNA

(EpoRmRNAn)

and

GATA-1

mRNA

(GATA1mRNAn) in steps 18 and 19. The nuclear mRNAs (EpoRmRNAn and
GATA1mRNAn) are translocated to the cytoplasm (EpoRmRNAc and GATA1mRNAc,
respectively), where they are either translated to their corresponding protein forms or
degraded (steps 20 – 25).
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EpoR and GATA-1 are present at basal levels in progenitor cells before the
addition of Epo. The basal expression of Epo receptor may be independent of GATA-1 as
there is also a Sp1 binding site on the 1.7 kb 5’-flanking region of the EpoR gene. Based
on current evidence, it appears that, as EpoR is transported to the cell membrane, it is
rapidly bound by JAK2 and homodimerizes. Accordingly, we have assumed 90% of
EpoR to be initially present in the dimeric state, 9% to be monomers bound by JAK2, and
1% to be free receptors. Activation and deactivation reactions of PI3K, PIP2, GATA-1,
and AKT are assumed to have Michaelis-Menten kinetics. AKT phosphorylation is
modeled as a two-step process65. Double phosphorylation of AKT by 3’phosphoinositide-dependent protein kinase 1 (PDK1) is necessary for its complete
activation66, 67. Dephosphorylation of PI3K*, PIP3, and AKTpp are implicitly modeled
without considering the rate of change of the phosphatases involved. The role of AKTpp
in GATA-1 activation is modeled as a single enzymatic step, encompassing both direct
(e.g., phosphorylation) and indirect (e.g., acetylation) mechanisms. It is important to note
that Epo may activate GATA-1 by AKT-independent mechanisms, but this does not
change the qualitative nature of the model (see minimal model below). The mRNA
transcription rate is assumed to saturate hyperbolically with active transcription factor
concentration, a rapid-equilibrium approximation68. The rate of translation is
approximated to be proportional to the concentration of the cytoplasmic mRNA69. All
degradation reactions are modeled with first-order kinetics.
2.2.2. Positive feedback loops
There are two feedback loops considered in this model. Since GATA-1* positively
autoregulates its own transcriptional rate, reactions 19, 21, and 24 drive the first positive
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feedback loop. This loop increases the concentration of inactive GATA-1 in the cell. The
strength of this feedback is governed by the parameter F1V19, the maximal transcriptional
rate of the GATA-1 gene, shown in reaction 19. GATA-1* is also shown to regulate the
synthesis rate of EpoRJD through reactions 18, 20, 22, 1, and 3, which start the second
positive feedback loop, whose strength is denoted by F2V18, the maximal rate of
production of EpoR mRNA. In this loop, GATA-1* upregulates the expression of
EpoRJD which in turn increases the number of complexes formed on the cell surface and
leads to the increase in the concentration of activated AKT kinase (AKTpp). In this
model, F1 and F2 determine the relative strengths of the feedback loops as V18 and V19 are
kept equal and constant. The core reaction in the model is the activation of GATA-1 by
AKTpp (reaction 16) and the two feedback loops work synchronously to drive this
reaction and produce GATA-1*, which in turn drives both of the feedback loops and also
regulates the transcription of other erythrocyte specific genes.
2.2.3. Nondimensionalization and computation
The full model, which consists of 18 ordinary differential equations derived from 27
reactions with 44 parameters, is given in Table 2.1. To simplify parameter estimation and
mathematical

analyses,

the

model

was

completely

nondimensionalized;

the

nondimensional forms of the differential equations and the parameters are given in the
Tables 2.2 and 2.3, respectively). In the nondimensional model, each reactant
concentration is normalized by the total concentration of its respective basal inactive
form. The species used in the mathematical analyses are Epo receptor homodimer
(EpoRJD), complex (EpoRJD*), activated AKT (AKTpp), and activated GATA-1
(GATA-1*). The respective nondimensional forms of these reactants are:
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A complete list of the nondimensional reactants and their initial conditions is
provided in Table 2.4. The nondimensional equations were solved using the Systems
Biology Toolbox (SBtoolbox) for MATLAB (The MathWorks, Natick, MA)70. Parameter
sensitivity and parameter estimation were also performed with SBtoolbox. MATLAB
was used for analyzing bistability and ultrasensitivity through steady-state response plots.
2.2.4. Parameter estimation and sensitivity analysis
Of the 44 parameters present in the model, 29 parameters were incorporated directly from
the literature, 8 parameters were refined from values provided in the literature, and the
remaining 7 parameters (V16, K16, V17, K17, F1, F2, k26) were estimated to fit time course
measurements of GATA-1 DNA binding activity during erythroid precursor commitment
and differentiation as reported by Dalyot et al. Of these 7 parameters, the steady-state
values of the reactants in the model are highly sensitive only to F1, F2, and k26. To
initially compare the model to these experimental data, a negative feedback loop was
added to account for the degradation of GATA-1* after progenitor commitment. This was
necessary since the experimental data covers a much broader temporal window of the
differentiation process, from GATA-1* production in progenitors to complete GATA-1
degradation in mature erythrocytes. We have assumed that the change in GATA-1 DNA
binding activity is due to corresponding changes in the levels of GATA-1*. The fitted
parameters were then used in mathematical analyses performed without the negative
feedback loop, as our model is only intended to analyze the commitment decision of the
progenitor cells much earlier in the differentiation process and not account for larger27

scale phenotypic changes that are observed in mature erythrocytes after commitment.
Tables 2.5 and 2.6 give the values of the estimated parameters and the initial conditions
of the reactants in the model.
Sensitivity analysis was performed for the Epo receptor dimer, complex, activated
AKT, and activated GATA-1 by perturbing all 44 parameters and obtaining the
normalized steady-state sensitivities (ranging from 0-1). EpoRJD steady-state levels are
most sensitive to the transcriptional rate of EPOR (F2V18) and to the translation and
degradation rate constants of cytosolic EpoR mRNA (k22 and k23, respectively) (Figure
2.3A). Epo receptor dimer is also highly sensitive to complex formation (k5) and to a
lesser extent to complex dissociation (k-5) and endocytosis (k6). Epo-EpoR complex
(Figure 2.3B) has a sensitivity profile similar to that of the receptor dimer, except that it
is more sensitive to the internalization rate constant of the complex (k6) and less sensitive
to binding kinetics (k5 and k-5). Activated AKT levels are sensitive to the activation and
deactivation of PIP3 and AKT [V9-V15, K9-K15 and k11] and to the transcriptional rate of
EPOR (F2V18) (Figure 2.3C). GATA-1* is most sensitive to the transcriptional rate of
GATA1 (F1V19) and to the translation and degradation rate constants of cytosolic GATA1 mRNA (k24 and k25, respectively). GATA-1* is also highly sensitive to its degradation
rate constant (k26) (Figure 2.3D). It is important to note that the sensitivity analysis was
performed while keeping the system in the biologically relevant on-state (F1 = 0.04, F2 =
0.123), which is F1-limited (cf. Figure 2.9B). Therefore, perturbation of F2 should not
affect the steady-state levels of GATA-1*. From the sensitivity analysis we can see that
the steady-state values of the receptor dimer, complex, and activated AKT are influenced
by feedback 2 (EpoR synthesis), whereas GATA-1* steady-state levels are influenced
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directly by feedback 1 (GATA-1 synthesis) and indirectly by feedback 2 (GATA-1
activation via EpoR synthesis).
Estimation of the unknown rate constants was performed by fitting the GATA-1*
time course with GATA-1 DNA binding ability during erythroid differentiation in
primary human liquid cultures. To fit the model with the experimental data, a simple
negative feedback was added to account for the decrease in the levels of GATA-1 after
progenitor commitment. The rate equations and the rate constants of the negative
feedback loop are given below:
Rate equations and initial condition:

Rate constants:
V28 = 6.90 x 10-5 s-1; V29 = 3.92 x 10-5 nM/s; K28 = 293.03 nM; K29 = 516.49 nM
The EpoR and GATA-1 mRNA profiles from this EpoR/GATA-1 model with
negative feedback were then compared with entirely independent microarray data from
differentiating CD34+ human hematopoietic progenitor cells (NCBI Gene Expression
Omnibus database (#GDS2431))71. As seen in Figure 2.2, the model trends compare
favorably with the experimental data. EpoR and GATA-1 mRNA levels are low at the
start of terminal differentiation. Upon Epo induction (day 0), both EpoR and GATA-1
mRNA expression levels increase and reach a peak at days 8-9 (late Basophilic
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Erythroblast/early Polychromatic Erythroblast stage) and their levels fall with further
maturation.
2.2.5. Identification of a generalized minimal model
To ascertain what topological features in the EpoR/GATA-1 model are responsible for its
robust bistability, the model was systematically reduced to a minimal form by stepwise
elimination of various linear topological motifs, including EpoR homodimerization,
PI3K/AKT cascading, multi-site phosphorylation, and individual transcription and
translation steps (data not shown). Conversely, both feedback loops were critical for
robust bistability (see Results).
The minimal model (Figure 2.4) consists of the following reactions. The cellsurface receptor and the inactive lineage specific transcription factor (InactiveTF) are
expressed at basal (ligand-independent) levels in the naïve cell. After addition of ligand, a
fraction of the cell-surface receptors become complexes (step 2) and transmit a
downstream signal to enzymatically activate the transcription factor (step 4). Constitutive
receptor endocytosis, complex internalization, and InactiveTF degradation reactions are
shown in steps 1, 3, and 8, respectively. The active transcription factor (ActiveTF) can
then upregulate the expression of both receptor and inactive transcription factor (steps 6
and 7, respectively). ActiveTF can be deactivated or degraded (steps 5 and 9,
respectively). The activation of transcription factor by complex and its deactivation are
modeled as single enzymatic steps and are assumed to have Michaelis-Menten kinetics.
Complex internalization and all degradation reactions are modeled to have first-order
kinetics. The transcription and translation reactions are modeled as a single step, where
the rate of protein formation is assumed to saturate hyperbolically with the concentration
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of active transcription factor. The state of the system is represented by the concentration
of ActiveTF; high levels denote the on-state (committed state) and low levels denote the
off-state (naïve state).
2.2.6. Nondimensionalization and computation of the minimal model
The dimensional and nondimensional forms of the minimal model, each consisting of
four differential equations, are provided in Tables 2.7 and 2.8, respectively. The species
present in the minimal model are ligand (L, time-invariant), receptor (R), complex (C),
inactive transcription factor (ITF), and active transcription factor (ATF). The
nondimensionalization was performed in a manner analogous to the EpoR/GATA-1
model (Tables 2.9 and 2.10):

The system of differential equations was solved analytically using Maple (Maplesoft,
Waterloo, Canada) and the full solution for all reactants is given in Table 2.11. Bistability
and bifurcation analyses were performed using MATLAB. The values of the kinetic
parameters in this model are given in Table 2.12.
Sensitivity analysis was performed for the reactants in the minimal model by
perturbing all 16 parameters and obtaining the normalized steady-state sensitivities. The
most sensitive parameters for each of the reactants are shown in Figure 2.5. Receptor (R)
steady-state levels were primarily sensitive to its transcriptional rate (F2V7) and complex
formation (k2). Complex (C) steady-state levels were most sensitive to receptor
transcriptional rate (F2V7) and complex endocytosis (k3). Inactive Transcription factor
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(ITF) levels were mainly sensitive to receptor transcription rate (F2V7), ITF transcription
rate (F1V6), complex endocytosis (k3), and activation of ITF by complex (V4, K4). Active
transcription factor (ATF) steady-state levels were largely sensitive to its degradation (k9)
and ITF transcription rate (F1V6). From this analysis, we observe that receptor and
complex steady-state levels are sensitive only to feedback 2; ITF levels are sensitive to
both feedback 1 and feedback 2; and, ATF levels are sensitive solely to feedback 1.

2.3. Results
2.3.1. Bistability and ultrasensitivity in the EpoR/GATA-1 network
Stimulus/response plots have been used to predict bistability, hysteresis, and
ultrasensitivity in molecular networks. The system is induced over a wide range of input
stimuli and the corresponding responses are obtained after the system reaches steady
state. The state of our EpoR/GATA-1 network is represented by the concentration of
GATA-1*; high levels (obtained from both accumulation and activation of GATA-1)
denote the on-state (committed state) and low levels denote the off-state (uncommitted
state). In this simulation, Epo was considered to be the stimulus and the responses of
important downstream effectors activated by the ensuing signals were analyzed. In Figure
2.6, the steady-state values of the nondimensionalized reactants [RJD, C, App, GA] are
plotted against the concentration of Epo normalized to its dissociation constant (Kd = 58
pM72). When [Epo] = 0, the system is in the off-state, with RJD at its basal steady-state
value of 0.45 and C, App, and GA all at zero, as there are no complexes. As the Epo
concentration increases from 0, the steady-state value of the Epo receptor dimer
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decreases (Figure 2.6A) as a result of complex formation (Figure 2.6B) and there is a
subsequent marginal increase in App and GA (Figure 2.6C and 2.6D). As the
concentration of Epo is further increased to 0.96Kd, the number of complexes formed
increases, but this is still not sufficient to maintain the positive feedback loops and the
system remains in the off-state. Only when the input stimulus exceeds 0.96Kd does the
system switch to the on-state, as the complexes can then generate enough AKTpp for
GATA-1* levels to exceed the threshold concentration needed to sustain the feedback
loops. Therefore, the system exhibits ultrasensitivity for a small perturbation in the
concentration of Epo about 0.96Kd. The on-state is accompanied by a large burst of
GATA-1*, an event known to precede the accumulation of various erythroid specific
genes. The system continues to remain in the on-state with further increase in Epo levels.
To explore whether this network can exhibit memory, the system was taken to the
on-state by increasing the concentration of Epo to its Kd value. The stimulus was then
reduced to 0.96Kd and the system was allowed to reach steady-state. It can be seen from
the plots that the system remains in the on-state as the active positive feedback loops can
sustain the system in the committed state. Thus, the downstream effectors in the system
exhibit hysteresis with respect to cytokine stimulus. As the Epo concentration is further
reduced from 0.96Kd to 0.008Kd, the steady-state value of RJD increases since less
complexes are formed and, in turn, there is a reduction in the levels of App; nonetheless,
the number of complexes is still sufficient to sustain the feedback loops and to maintain
high levels of GATA-1*. As Epo levels are reduced below 0.008Kd, the system switches
back to the off-state due to a lack of sufficient Epo-mediated signaling. When the system
is in the committed state, removal of the stimulus below the threshold level does not
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immediately bring the system back to the off-state, instead exhibiting bistability over a
large range of stimulus concentration. This bistable expression of GATA-1* can reduce
the sensitivity of the system to noise by necessitating a high Epo concentration to initially
achieve the on-state and, thereafter, by providing marked robustness to the active state.
Though the on-state is still maintained when the stimulus level is reduced approximately
120-fold below the threshold concentration, further decreases in Epo concentration drive
the system back to the off-state, suggesting that it is not completely irreversible. This is in
accord with the phenotypic change observed after commitment during which the cell
becomes increasingly independent of EpoR signaling and GATA-1 levels start to fall.
The high expression of GATA-1 achieved by Epo induction at commitment can initiate
chromatin rearrangements and expression of lineage specific genes, thereby ‘locking’ the
cell in the mature state. The steady states plotted in Figure 2.6 are only the stable values;
the unstable steady states are omitted, as they are not experimentally accessible.
2.3.2. Pretreatment can change the threshold concentration of the stimulus
The steady-state response plot of GA (Figure 2.6D) shows that the Epo concentration has
to be greater than 0.96Kd for the system to be in the on-state. Is there a way to attain the
on-state for values of Epo less than the threshold concentration? Given the memory
implicit in this network, we hypothesized that transient pretreatment of cells with high
concentrations of Epo should influence their commitment decision since the switch to the
on-state is determined by the number of complexes needed to sustain the positive
feedback loops. If the cell were pretreated with a high concentration of Epo for a fixed
amount of time, it should still be possible to achieve the on-state even if the Epo
concentration were then reduced to a level lower than the threshold concentration
34

(0.96Kd), since there would be an appropriate accumulation of multiple activated species
during pretreatment. To test this using our model, the concentration of Epo during
pretreatment was fixed at its Kd value and was then reduced to the value given on the xaxis in Figure 2.7. The minimum pretreatment time required for the system to attain the
on-state for a range of constant Epo concentrations lower than the threshold concentration
is plotted in Figure 2.7. The corresponding plots of RJD, C, App, and GA requirements to
achieve the on-state for lower Epo concentrations are similar and are given in Figure 2.8.
For Epo concentrations greater than 0.96Kd, the threshold concentration, the cell does not
require pretreatment for commitment. As the Epo concentration is reduced from 0.96Kd
to 0.008Kd (a range that corresponds precisely to the bistable window in Figure 2.6), the
pretreatment time required to accumulate sufficient GATA-1* to attain the on-state
increases exponentially. Reducing the Epo concentration below 0.008Kd, does not bring
the system to the on-state for any pretreatment time, as the system is in the monostable
off-state below this Epo concentration (see Figure 2.6).
2.3.3. Double positive feedback loops lead to robust bistability
The EpoR/GATA-1 network consists of two positive feedback loops that coordinate to
create a burst of GATA-1*, an event critical for erythrocyte commitment. The first
feedback loop is the transcription of GATA1 by GATA-1*, which increases the
concentration of inactive GATA-1 (substrate), and the second feedback loop is the
transcription of EPOR by GATA-1*, which leads to an increase in the levels of AKTpp
(enzyme) in the presence of Epo. Parameters F1 and F2 govern the maximum
transcriptional rates of GATA1 and EPOR, respectively, and hence represent the strength
of the GATA-1*/GATA-1 and GATA-1*/EpoR/AKTpp feedback loops, respectively.
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The parameter-fitted values of F1 and F2 are 0.04 and 0.123, which correspond to a
steady-state value of GA = 295 as seen in Figure 2.6D. In addition to other epigenetic
factors, one possible explanation for the difference in the transcriptional rates of GATA1
and EPOR could be the distinct mechanisms by which GATA-1 binds to its consensus
sequence present in the promoter regions of these genes. It should be noted that the two
positive feedback loops are interdependent (linked via the GATA-1 activation reaction;
reaction with light gray background in Figure 2.1) and are necessary for the commitment
decision to accumulate GATA-1*. When F1 = 0, the cell cannot make more inactive
GATA-1, and can only activate the existing low levels of GATA-1, so the system stays in
the off-state for any value of F2 > 0; similarly, when F2 = 0, the cell cannot make enough
surface complexes to activate GATA-1 via AKTpp, so the system remains in the off-state
for any physiologically reasonable value of F1 > 0. For very large values of F1, however,
high levels of GATA-1* can be achieved, albeit in a manner that does not impart memory
to the system (the stimulus/response plot in this case is hyperbolic and monostable
everywhere).
Figure 2.9A shows a 3D plot of the steady-state value of GA as a function of F1
and F2 when the Epo concentration is equal to its Kd. Changing the values of F1 and F2
can switch the system from the off-state to the on-state as well as change the set point of
the reactants – specifically GA – in the on-state. As seen from the plot; for F1 = 0, F2 > 0
or F1 > 0, F2 = 0, the system is in the off-state. For the estimated value of F1 = 0.04, as we
increase F2 from 0 the system remains in the off-state until F2 reaches 0.118. Any
increase of F2 over 0.118 causes the system to switch to the on-state with a GA set point
value of 295. Further increasing F2 does not change the value of GA and the system
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remains in the on-state. For the estimated value of F2 = 0.123, as we increase F1 from 0
the system remains in the off-state until F1 = 0.01, at which point the system switches to
the on-state with a low GA set point value. As we further increase F1 to 0.04, the system
stays in the on-state and increases the GA steady-state value to the estimated value of
295. When F1 is increased beyond 0.04, the steady-state value of GA increases and
saturates at an F1 value of 1.2.
A top view of the 3D plot is given in Figure 2.9B to address the effect of changes
in F1 and F2 on the set point of GA in the on-state. In this phase diagram, the on-state is
divided into two regions: F1-limiting, where an increase in F1 (but not F2) will increase
the set point of GA in the on-state, and F2-limiting, where an increase in F2 (but not F1)
will increase the set point of GA in the on-state. It can also be seen that the critical value
of F2 above which the system attains the on-state slightly decreases as we increase F1 and
the critical line eventually asymptotes at F2 = 0.05 for very high F1. The EpoR/GATA-1
system is likely to always be F1-limited because of the extremely high GATA-1 levels
required to be F2-limited.
Figure 2.10 shows the steady-state response plots of GA for several values of F1
and F2 (analogous to Figure 2.6D). In Figure 2.10A, F1 is kept constant at 1.8 and F2
levels are varied between 0.15 and 2.00, to span both the F1 and F2-limiting regions (see
Figure 2.9B). For F2 = 0.15, the threshold concentration of Epo needed to switch the
system to the on-state is 0.85Kd. As F2 is increased, the threshold Epo concentration
decreases and the system reaches the on-state for lower stimulus values. It can also be
seen that the set point value of GA in the on-state is dependent on F2 only in the F2limiting region. The bistable window shown here is comprised of a constant and a
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variable on-state GA set point region. The constant on-state GA region is at its maximum
width in the F1-limiting region (F2 = 2.0) and decreases for F2 values closer to the F2limiting region (F2 = 0.40, 0.25). For F2 values in the F2-limiting region (F2 = 0.20, 0.15),
the on-state GA set point varies throughout the bistable window and decreases as the Epo
concentration is decreased. In Figure 2.10B, F2 is kept constant at 0.20 and F1 is varied
from 0.1 and 2.0. Increasing F1 value does not change the threshold concentration of Epo
needed to achieve the on-state; however it increases the set point of GA in the on-state.
Similar to Figure 2.10A, the constant on-state GA region in the bistable window
decreases when moving from an F1-limiting region to an F2-limiting region.
2.3.4. Bistable expression of GATA-1*
The steady-state response plot in Figure 2.6D shows the wide range of Epo
concentrations in which GATA-1* exhibits bistable expression for the fitted F1 and F2
values. To understand the influence of the two positive feedback loops in defining the
bistable window, we plotted the monostable (either ON or OFF) and bistable (ON and
OFF) GATA-1* regions as a function of Epo concentration and feedback strength. Here,
the F1 and F2 values are chosen to cover both the F1- and F2-limiting regions as shown in
Figure 2.9B. In Figure 2.11A, a log-log plot of F1 vs. [Epo]/Kd, with F2 constant (0.20),
shows the regions of monostable and bistable expression of GATA-1*. At low F1 values,
the system only achieves bistability for a narrow range of Epo concentrations. As we
increase F1, the bistable window increases and remains constant for larger F1 values. The
increase in the bistable window is only due to the decrease in the bistable-on to
monostable-off transition concentration, as the bistable-off to monostable-on threshold
concentration remains constant for all values of F1. This reveals that the Epo
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concentration at which the system initially switches to the on-state is independent of F1.
However, F1 governs the extent of memory in the system by changing the Epo
concentration at which the system switches from the on-state to the off-state. Figure
2.11B shows a semi-log plot of F2 vs. [Epo]/Kd, with F1 constant (1.8). For values of F2
less than 0.08, the system remains in the off-state for all Epo concentrations. The system
attains the on-state for higher F2 values and also exhibits bistability for a wide range of
Epo concentrations. In contrast to Figure 2.11A, the bistable window in Figure 2.11B
shifts as we increase F2 due to a substantial decrease in the bistable-on to monostable-off
transition concentration as well as a smaller decrease in the bistable-off to monostable-on
threshold concentration. This indicates that F2 plays a role in determining the Epo
concentration at which the system reaches on-state as well as in governing the magnitude
of memory in the system.
Since basal levels of inactive GATA-1 are low, the system needs both F1 (for
accumulation of GATA-1) and F2 (for activation of GATA-1) to attain the on-state
(accumulation of activated GATA-1). For systems having a high basal expression level of
inactive transcription factor or lineage specific receptor (though neither is the case for the
erythrocyte differentiation problem), it becomes relevant to examine how bistability may
be achieved. Can such systems potentially attain the on-state* (activation, no
accumulation) even if F1 = 0 or F2 = 0? We tested this using our EpoR/GATA-1 model,
with F1 fixed at 0. Figure 2.11C shows the bistable expression of the active transcription
factor in the absence of F1. For a given F2, the Epo concentration at which the system
attains the on-state does not change when compared with Figure 2.11B, but the respective
concentration at which the system switches back to the monostable off-state is increased
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dramatically, thus narrowing the bistable window, or memory, in the system. A system
which has feedback 1 (upregulation of GATA-1 by GATA-1*) but no feedback 2
(upregulation of EpoR by GATA-1*) does not exhibit bistability for any value of F1,
confirming the observation that autoregulating positive feedback loops without
cooperativity do not show bistability in deterministic models; bistability in a system
lacking feedback 2 can be recovered by incorporating the need for transcription factor
dimerization for activation (data not shown). In summary, this shows that the bistability
and ultrasensitivity achieved in the Epo-GATA-1 model were primarily due to the
presence of feedback 2, and that feedback 1 only plays a role in increasing the extent of
memory in the system. The values of F1 and F2 may also change during the differentiation
process, thus dynamically modulating the robustness of the system, though this timedependence was not considered here.
2.3.5. Construction of a generalized minimal model
The EpoR/GATA-1 model exhibits ultrasensitivity and bistability for a wide range of
Epo, F1, and F2 values. The structural aspects of the EpoR/GATA-1 model are the two
linked positive feedback loops, receptor homodimerization, PI3K/AKT signaling
pathway, double phosphorylation of AKT, and the transcription and translation steps. We
systematically developed and tested various sub-models of the parent model to identify
the dispensable steps and to obtain a generalized minimal model that still retains the
ultrasensitivity and robust bistability of the parent model (data not shown). This analysis
revealed that the two positive feedback loops were both necessary and sufficient for
recapitulating the overall system behavior of the full EpoR/GATA-1 model. This reduced
lineage-specific receptor/transcription factor model (Figure 2.4) includes only four time40

dependent species: receptor (R), complex (C), and inactive (ITF) and active (ATF)
transcription factor. This model was solved analytically and the exact solution for each of
the four reactants was determined. The steady-state response plots for these reactants for
selected values of F1 and F2 are given in Figure 2.12. The bistability plots of ATF (Figure
2.13) in the minimal model closely mimic those in the EpoR/GATA-1 model (Figure
2.11).
2.3.6. Bifurcation analysis of the minimal model
Unlike the EpoR/GATA-1 model, the minimal model can be solved analytically, which
can prove useful in understanding the contributions of each of the two positive feedback
loops to the overall behavior of the system. The solution curves of ATF are plotted
against L (normalized to its Kd) for various values of F2 holding F1 constant at 20 as
shown in Figure 2.14A. The solid lines and the dotted lines denote the stable and unstable
roots, respectively. For low values of F2 (0.01), the system has only two real roots (one
stable and one unstable) and is purely monostable for all ligand concentrations. As F2
value is increased to 0.1, the expression of the ActiveTF becomes narrowly bistable, with
the endpoints of this bistable window defined by two saddle-node bifurcations that appear
to depend on F2 but not on F1 (see below). The degree of bistability increases
dramatically as F2 is increased to 1 and then to 10. It can be seen that, for these F2 values,
the solution curves intersect to form a transcritical bifurcation. The transcritical set point,
which constrains the maximum theoretical value of ATF, seems to be independent of F2.
The transcritical bifurcation also divides the bistable window into F1-limiting (right;
constant on-state value) and F2-limiting regions (left; variable on-state value). For low F2
values, the bistable region is completely F2-limited and as we increase F2, the bistable
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region becomes increasingly F1-limited. Finally, it can also be observed that the threshold
ligand concentration to achieve the on-state decreases as we increase the F2 value.
Figure 2.14B shows the bifurcation diagrams for ATF plotted against L by
varying F1 and keeping F2 constant at 10. Unlike the previous case (Figure 2.14A), the
system can achieve bistability over a narrow range of L by forming two saddle-node
bifurcations even when F1 is zero. As we increase F1, the size of the bistable window and
the on-state set point value both increase. At a critical value of F1 (here 4.3), the
maximum bistable window is achieved, coincident with the appearance of an apparent
subcritical pitchfork bifurcation at the lowest value of L at which the system is still
bistable. At this F1 value, the set point of the ATF in the bistable region is completely F1limited. As F1 is increased beyond 4.3, the solution curves form a transcritical bifurcation
similar to that seen in Figure 2.14A. As we further raise the value of F1 to 20 and then
200, the value of L at which the transcritical bifurcation occurs shifts from low to high,
making the bistable region increasingly F2-limited. This is in contrast to Figure 2.14A,
where the transcritical bifurcation point moves from right to left and the bistable region
becomes increasingly F1-limited as we increase F2. Importantly, increasing F1 augments
the maximum on-state set point value of ATF but has no effect on the threshold ligand
concentration necessary for achieving the on-state.
By comparing the bifurcation plots of ATF in Figure 2.14 with various plots of
activated GATA-1 (Figure 2.6D, Figure 2.10, and Figure 2.11), the following conclusions
can be deduced for the EpoR/GATA-1 system: the width of the bistable region and the
range of GATA-1* values in the on-state can both depend on F1 (under F1-limited
conditions) and/or F2 (under F2-limited conditions); the maximum GATA-1* value in the
42

on-state is determined by F1; the threshold Epo concentration at which the system
switches to the on-state is dictated by F2; the maximum bistable window achievable is set
by F2; and, the system requires an F2 value above a critical threshold in order to exhibit
bistability.

2.4. Discussion
EpoR and GATA-1 are both essential for erythrocyte precursor commitment and
differentiation, and we present here a deterministic model that bidirectionally links the
lineage-specific receptor and transcription factor. Based on recent biochemical data, we
chose the PI3K/AKT cascade as the signaling pathway that connects EpoR and GATA-1.
The model accounts for basal expression of EpoR and GATA-1, Epo binding to EpoR to
activate the PI3K/AKT pathway, activation of GATA-1 by phosphorylated AKT, positive
autoregulation of GATA-1 expression by GATA-1*, and upregulation of EpoR
expression by GATA-1*.
In order to gain mechanistic insights into system behavior, we chose to focus on
this small set of critical molecular effectors implicated in erythropoiesis. However, it
should be noted that our explicitly modeled topology represents only a fraction of the full
regulatory network and, therefore, inferring cell fate from the level of a single metric
(e.g., GATA-1*) represents an approximation of a high-dimensional attractor55,
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regulation76, and the degradation of DNA-bound GATA-177. Also, the JAK2/STAT5
pathway activated by Epo can initiate a negative feedback loop on the PI3K/AKT
pathway by activating SOCS proteins which can suppress Epo receptor signaling78, 79.
Our model, despite neglecting these additional complexities, can nevertheless effectively
capture the system dynamics observed experimentally (see Figure 2.2).
Through steady-state response plots (Figure 2.6) and bistability plots (Figure
2.11), it was revealed that the EpoR/GATA-1 network can exhibit ultrasensitivity and
bistability. Since these properties may play important roles in erythrocyte commitment, it
was informative to probe the role of positive feedback in such a topology. As shown in
Figure 2.14A, positive receptor feedback can ultrasensitize the system to ligand and can
generate a considerable memory effect once the on-state is achieved. Other transcription
factors (e.g., GATA-380) are believed to be intracellularly amplified through a classical
autoregulatory positive feedback loop: synthesis of the new transcription factor is
followed by dimerization (or higher order oligomerization) and the complex is then
transcriptionally active. If this is sufficient for programming cell fate, why, then, might a
transcription factor such as GATA-1 have evolved to upregulate a lineage-specific
receptor as well?
The answer may lie in the different modes of activation. While the dimerization
step closes the positive feedback loop for some transcription factors, experimental
evidence suggests that GATA-1 binds DNA as a monomer81, 82 and shows no detectable
DNA-binding ability before the addition of Epo. Thus, EpoR signaling may be necessary
to close the GATA-1 autoregulatory loop by activating the transcription factor via AKT.
By upregulating EpoR to increase its own activation, GATA-1 can effectively mimic the
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molecular cooperativity of other transcription factors in generating robust network
bistability without employing any cooperative reactions. (The importance of
cooperativity in achieving bistability is restricted to the class of deterministic models
discussed in the present work; it is indeed possible to achieve steep sigmoidal responses
through nonidealities such as molecular crowding83, stochastic focusing84, and
dimensionally-restricted reactions.)
Two unique elements of the EpoR/GATA-1 model should be highlighted. First,
by decoupling the synthesis and activation steps in the positive GATA-1 autoregulatory
loop, a cell may be able to independently tune the switching threshold, the on-state
expression level, and the extent of memory in the network by separately modulating F1
and F2 (e.g., epigenetically). Second, there is an external checkpoint (Epo) that modulates
this autoregulatory loop. This is attractive because it provides a novel and meaningful
link between canonically extrinsic (cytokine) and intrinsic (transcription factor) signals in
regulating not only cell survival but also maturation.
The strengths of the positive feedback loops are governed by the rates of
transcription of GATA1 (F1) and EPOR (F2). The estimated values of F1 and F2 are 0.04
and 0.123, respectively. The difference in the rates of transcription of EPOR
(chromosome 19p13.2) and GATA1 (chromosome Xp11.23) may be due to the distinct
binding mechanisms of GATA-1 to these promoters, dissimilarities in the ease of
accession of the GATA-1 binding sites, and the recruitment of other cofactors that may
regulate EPOR and GATA1 expression differently. GATA-1 also interacts with other
factors, notably the ubiquitous transcription factor Sp1, erythroid restricted factor EKLF,

45

and friend of GATA-1 (FOG1) that may alter its transcriptional activity among the
various GATA-1 regulated genes29.
Though treated as constants in our model, F1 and F2 may also change temporally
during commitment and differentiation due to additional biophysical (e.g., chromatin
remodeling) and biochemical (e.g., co-factor upregulation/downregulation) processes.
Accordingly, the values of F1 and F2 may also vary substantially between primary cells
and immortalized lines, and may even differ among cell lines, depending upon how far a
cell line is from commitment towards the erythrocyte lineage, relative expression of
GATA-1 cofactors, basal levels of EpoR and GATA-1 expression, and expression of
antagonistic transcription factors driving other lineages. Cell-specific feedback strengths
that differ significantly from those used in our models may serve to attenuate or amplify
the actual effects on the network.
Finally, system-level properties such as bistability and ultrasensitivity that may be
generally applicable to lineage commitment can be experimentally corroborated.
Pretreatment of progenitor cells with ligand, as outlined in the Results (Figure 2.7), can
be performed to show expected hystereses in transcription factor activation and lineage
commitment. Additionally, the models elucidate how the steady-state response profiles of
activated transcription factor can be influenced by F1 and F2, and these can be
experimentally validated by using pharmacological inhibitors or RNA interference to
exogenously manipulate the values of F1 and F2. While the results presented here are
motivated by the EpoR/GATA-1 network and its critical role in erythropoiesis, it will be
interesting to see whether similar topologies are uncovered in other cell systems which
enable their hosts to make robust decisions in response to external stimuli.
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Figure 2.1

Figure 2-1 EpoR-GATA1 model
Kinetic model of the EpoR/GATA-1 network implicated in erythrocyte progenitor commitment.
EpoR and GATA-1 are present at low basal levels before the addition of Epo. Epo binds to EpoR
homodimers (EpoRJD), thereby activating AKT through the PI3K/AKT pathway. Doubly
phosphorylated AKT (AKTpp) activates GATA-1 directly and indirectly through covalent
modifications (modeled here as a single step). GATA-1*, the activated form of the transcription
factor, upregulates GATA-1 and EpoR gene expression by binding to GATA motifs present in the
response elements of their corresponding genes. The core reaction of the model is the activation
of GATA-1 by AKTpp and is highlighted with a light gray background. The reactants in the
white boxes comprise one feedback process (with transcriptional strength F1), a synthesis loop
that generates more inactive GATA-1 (substrate), and the species in the dark gray boxes represent
a second feedback process (with transcriptional strength F2), an Epo-regulated loop that makes
more AKTpp (enzyme). Both feedback loops provide inputs to the core reaction to form GATA1* (product). All reactants except Epo and JAK2 are time-variant. Reactions (1-6, 11, 20-21, 23,
and 25-26), (7-10, 12-17, 22, and 24), and (18 and 19) are modeled with mass- action, MichaelisMenten, and rapid-equilibrium kinetics, respectively. The species names ending with mRNAc and
mRNAn denote cytoplasmic and nuclear mRNA, respectively. Double-headed
and singleheaded
solid arrows indicate reversible and irreversible reactions respectively. Dashed
arrows specify irreversible reactions (transcription, translation) in which reactants are not
consumed. *, p, and pp denote the activated, singly phosphorylated, and doubly phosphorylated
forms of species. All reactions going to null denote first-order degradation processes. The values
of the rate constants shown in the figure are given in Table 2.5.
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Figure 2.2

Figure 2-2 Comparison of the EpoR/GATA-1 model with experimental data
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(A) GATA-1* time course plot generated from the EpoR/GATA-1 model is fitted to the
experimental data to obtain the unknown kinetic parameters. (B & C) Relative EpoR and GATA1 mRNA plots obtained after parameter estimation are compared with microarray data during
CD34+ progenitor differentiation. (D) Characterized stages of red blood cell development during
terminal differentiation are drawn to scale using the x-axis in plots A, B, and C. The
EpoR/GATA-1 model is relevant only for erythrocyte commitment (CFU-E to Baso EB) and does
not cover the latter stages of differentiation (from Poly EB (grayed out))
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Figure 2.3

Figure 2-3 Parameter sensitivity analysis
(A) Epo receptor dimer [RJD]. (B) Epo-Epo receptor complex [C]. (C) Activated AKT [App].
(D) Activated GATA-1 [GA].
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Figure 2.4

Figure 2-4 Generalized minimal model for lineage commitment
Receptor and Inactive Transcription Factor (InactiveTF) are present at basal levels before the
addition of ligand. Ligand binds to Receptor to form Complex and activates InactiveTF to form
Active Transcription Factor (ActiveTF). ActiveTF upregulates the levels of InactiveTF and
Receptor through two positive feedback loops. Reactions (1-3, 8, and 9), (4 and 5), and (6 and 7)
are modeled with mass-action, Michaelis-Menten, and rapid-equilibrium kinetics, respectively.
Double-headed
and single- headed
solid arrows indicate reversible and irreversible
reactions, respectively. Dashed
arrows specify irreversible transcriptional activation and
translation reactions (modeled as a single step). All reactants except ligand are time variant. All
reactions going to null denote first-order degradation processes. The values of the rate constants
shown in the figure are given in Table 2.12. (inset) A further simplified schematic of the minimal
model highlighting the two feedback loops. L, R, ITF, and ATF denote the nondimensional forms
of Ligand, Receptor, InactiveTF, and ActiveTF. Basally expressed R converts basally expressed
ITF to ATF only in the presence of L. ATF upregulates itself by inducing the expression of both
ITF (with transcriptional strength F1) and R (with transcriptional strength F2). It should be noted
that positive feedback to ITF is intrinsically regulated, whereas positive feedback via R (to
activate ITF) is dependent on the external stimulus L.
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Figure 2.5

Figure 2-5 Normalized steady-state sensitivities of the reactants in the minimal model
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Figure 2.6

Figure 2-6 Nondimensionalized steady-state response plots
(A) Epo receptor dimer [RJD]. (B) Epo-Epo receptor complex [C]. (C) Activated AKT [App].
(D) Activated GATA-1 [GA]. The stimulus, Epo, is normalized to its Kd value and each
downstream effector is normalized to the total concentration of its respective basal inactive form.
The plots show that, for the fitted values of F1 (0.04) and F2 (0.123), the system is ultrasensitive to
Epo and exhibits bistability for a wide range of Epo concentrations (0.008Kd to 0.96Kd).
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Figure 2.7

Figure 2-7 Pretreatment time plot
Minimum pretreatment time required for the system to attain the on-state for a range of Epo
values lower than the threshold concentration (0.96Kd). Epo is normalized to its Kd. The
pretreatment concentration of Epo is kept at its Kd value and is thereafter reduced to the value
given on the x-axis. The plot suggests that for Epo concentrations greater than 0.96Kd, the cell
should not require pretreatment and, for values less than the threshold concentration, the
pretreatment time increases dramatically with decreases in Epo concentration. For Epo values less
than 0.008Kd, the system will always remain in the monostable off-state for any pretreatment time
(cf. Figure 2.6).
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Figure 2.8

Figure 2-8 Minimum reactant concentration plot
Nondimensional minimum initial effector concentrations required for the system to achieve the
on-state for a range of Epo concentrations lower than the threshold concentration (0.96Kd). Epo is
normalized to its Kd value. (A) Epo receptor dimer [RJD]. (B) Epo-Epo receptor complex [C]. (C)
Activated AKT [App]. (D) Activated GATA-1 [GA].
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Figure 2.9

Figure 2-9 Effect of the two positive feedback loops on the on-state GA value
(A) Steady-state GA values as a function of F1 and F2; Epo is kept at its Kd value. For the
estimated values of F1 (0.04) and F2 (0.123), the system is strongly F1-limited. (B) Corresponding
phase diagram of the 3D plot showing the off-state region, the F1-limited on-state, and the F2limited on-state. Increasing the values of F1 and F2 increases the on-state set point of GA in the
F1-limited and F2-limited regions, respectively. The EpoR/GATA-1 system is likely to behave as
an F1-limited system due the high GA values required to be F2 limiting.
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Figure 2.10

Figure 2-10 Steady-state response plots of GA for various values of F1 and F2
Steady-state response plots of GA for various values of F1 and F2, spanning both the F1- and F2limiting regions. (A) Changing F2 keeping F1 constant at 1.8. (B) Changing F1 keeping F2
constant at 0.20.
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Figure 2.11

Figure 2-11 Bistable expression of GATA-1*
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(A) A log-log plot showing the change in the bistable expression of GATA-1* for varying F1 (F2
= 0.20). The threshold Epo concentration needed to achieve the on-state appears to be
independent of F1. The maximum bistable window achievable is dependent on F2; however, the
width of the bistable window is F1-dependent for lower F1 values. (B) A semi-log plot showing
the bistable expression of GATA-1* for changing F2 values (F1 = 1.8). There appears to be a
threshold F2 value below which the system is purely monostable. Increasing F2 increases the
width of the bistable window and, to a lesser extent, decreases the threshold Epo concentration
required to reach the on-state. (C) Narrow bistable expression of GATA-1* for various F2 values
when F1 = 0. The ON* state denotes an on-state due to activation but no accumulation. This state
would not commit a cell to differentiate due to low basal levels of GATA-1. When F2 = 0, the
system is monostable for any F1 value (e.g., the x-axis in Figure 2.11B).
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Figure 2.12

Figure 2-12 Nondimensionalized steady-state response plots for the minimal model
Nondimensionalized steady-state response plots showing both the stable (solid) and unstable
(dotted) roots of the reactants in the minimal model: (A) Receptor [R]. (B) Complex [C]. (C)
Inactive Transcription Factor [ITF]. (D) Active Transcription Factor [ATF]. The
nondimensionalized stimulus, L, is the ligand concentration divided by its Kd value and each
downstream effector is normalized to the total concentration of its respective basal inactive form.
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Figure 2.13

Figure 2-13 Bistability plots of ActiveTF
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(A) A log-log plot showing the change in the bistable expression of ActiveTF for varying F1 (F2 =
10). (B) A log-log plot showing the bistable expression of ActiveTF for varying F2 (F1 = 20). (C)
Bistable expression of ActiveTF for various F2 values when F1 = 0. The ON* state denotes an onstate due to activation but no accumulation. This state would not commit a cell to differentiate
due to low basal levels of InactiveTF. When F2 = 0, the system is monostable for any F1 value
(not shown).
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Figure 2.14

Figure 2-14 Bifurcation analysis for the minimal model
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(A) Solution curves obtained from the analytical solution of nondimensionalized Active
Transcription Factor (ATF) are plotted against ligand concentration normalized to its Kd (L) by
varying F2 (0.01, 0.1, 1, and 10); F1 is held constant at 20. The solid lines and the dotted lines
denote the stable and unstable roots respectively. For low F2 values, the system is purely
monostable. As we increase F2, two saddle-node bifurcations emerge and they determine the
width of the bistable window and the threshold ligand concentration necessary to reach the onstate. As we further increase F2, the solution curves intersect to form a transcritical bifurcation.
The saddle-node set points and the transcritical set point (maximum achievable on-state value)
are F2- and F1-dependent, respectively. (B) F1 is varied (0, 4.3, 20, and 200); F2 is held constant at
10. The system can achieve bistable expression of ATF even when F1 = 0. As we increase F1, the
bistable window increases and reaches a maximum width, which is determined only by the F2
value. Increasing F1 further increases the on-state set point value of ATF but has no effect on the
threshold ligand concentration required to reach the on-state.
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Table 2.1
Table 2-1 Rate equations for EpoR/GATA-1 erythrocyte commitment model
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Table 2.2
Table 2-2 Nondimensional rate equations for EpoR/GATA-1 model
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Table 2.3
Table 2-3 Nondimensional parameters for EpoR/GATA-1 model
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Table 2.4
Table 2-4 Nondimensional ratios and initial conditions of the reactants
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Table 2.5
Table 2-5 Values of the kinetic parameters in the EpoR/GATA-1 model
Michaelis-Menten constants (K7 – K10, K12 – K19) are given in nM; V7, V9, and V16 are given in s1
; V8, V10, V12 – V15, V17 – V19 are given in nM/s. First- and second-order rate constants are given
in s-1 and nM-1s-1 respectively. Numbers in brackets denote the values given in the literature
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Chapter 3
Heterogeneity in the expression of EpoR and GATA1 is
positively correlated during erythropoiesis

3.1. Introduction
Cell differentiation is the process during which a progenitor cell commits towards a
particular lineage and remodels its transcriptome towards that lineage-restricted state.
The process of lineage-commitment is believed to precede the drastic phenotype change
during differentiation. During commitment, the progenitor cell makes a fate-decision
between proliferation and one of the several available differentiation states.
Lineage-specific cytokines and transcription factors are shown to be absolutely
necessary to robustly reach mature cell states1-7. Cytokines are cell-extrinsic factors that
bind to their cognate receptors on the progenitor cell surface and promote signals that
help in the survival, proliferation and differentiation towards a specific lineage. Lineagespecific transcription factors are cell-intrinsic factors that transcriptionally regulate most
of the lineage-specific genes. It has been heavily debated whether the cell-fate
commitment in hematopoiesis is an instructive or a stochastic process1, 8, 9. According to
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the instructive theory, external cues such as cytokines regulate the process of cell
commitment and bias the progenitor cell to a specific lineage, whereas the stochastic
theory suggests that each progenitor cell has been pre-committed by the differential
expression of lineage-specific transcription factors and cytokines merely provide survival
and proliferation signals during differentiation. Recent groundbreaking studies using
single-cell imaging techniques have unambiguously shown that cytokines can instruct
cells during differentiation10. However, the extent of this instruction and the topological
links between lineage-specific cytokine receptor signaling and lineage-specific
transcription factor upregulation are still unclear.
Progenitor cells tend to express low levels of all of the receptors and transcription
factors that are specific to the various lineages to which they can potentially commit, a
process known as transcriptional priming11. During differentiation, a specific
transcription factor gets upregulated and, through cross-antagonism, downregulates other
lineage-specific transcription factors2. Due to this, the heterogeneity in the expression of
the transcription factors is shown to be directly correlated with their lineage choices3.
However,

correlations

between

lineage-specific

receptor

expression

and

the

corresponding transcription factor or lineage specification have not been studied. Here,
we study these previously unexplored correlations using erythropoiesis as a model
system.
Erythropoietin (Epo) is a cytokine that binds to the Epo receptor (EpoR) present
on erythroid progenitor cells and provides signals of survival, proliferation and
commitment towards erythropoiesis12-14. Of the several erythroid-specific transcription
factors, GATA1 is believed to be the master regulator of erythropoiesis as it binds to
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response elements upstream of most of the enzymes necessary for hemoglobin synthesis
and upregulates their expression15-17. Previous studies have shown that GATA1 can
autoregulate its own transcription as well as regulate the transcription of EpoR18-24. Also,
recent biochemical evidence shows that EpoR signaling can directly result in posttranscriptional modification of GATA1 (acetylation and/or phosphorylation) and enhance
its DNA binding and transactivation capabilities25-32.
Based upon these experimental observations, we previously developed a minimal
model to analyze the topological connections between GATA1 and EpoR33. The minimal
topology for accumulation of active GATA1 contains two positive feedback loops: an
autofeedback loop that produces inactive GATA1 and an Epo-dependent, EpoR-mediated
feedback loop that activates GATA1 (Figure 3.1). Dynamical systems modeling of this
topology suggests that the presence of these two feedback loops can not only offer a
direct positive correlation in the upregulation of GATA1 and EpoR, but can also provide
cellular memory with respect to external cues, thereby establishing robustness in lineage
commitment during differentiation.
In this study, using an erythrocyte progenitor cell line, we experimentally
demonstrate that hemoglobin synthesis is highly switch-like in response to Epo and cells
undergoing lineage commitment possess memory of earlier Epo signals. We show that
total GATA1 and cell-surface EpoR are indeed co-upregulated and follow a synchronous
expression pattern during differentiation, confirming the presence of autofeedback and
receptor-mediated positive feedback loops, respectively. Our results also show that the
heterogeneity in EpoR expression during early-stage lineage commitment is positively
correlated with GATA1 expression, reinforcing the topological connection between
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lineage-specific receptor and transcription factor even in the presence of significant noise.
Moreover, due to this positive association and its consequent effect on cell phenotype, we
show that differential expression of EpoR in progenitor cells can be a marker for
erythrocyte commitment, with cells expressing high levels of EpoR having significantly
accelerated kinetics of differentiation. Our study highlights the interplay between cellextrinsic and cell-intrinsic factors in determining lineage commitment. These findings
may be of general applicability to other lineage-specific receptor and transcription-factor
pairs during differentiation, particularly in hematopoiesis.

3.2. Materials and Methods
3.2.1. Cell culture
UT-7/GM cells were kindly provided by Dr. Norio Komatsu (Juntendo University School
of Medicine) and Dr. Kenneth Kaushansky (University of California, San Diego).
Recombinant human GM-CSF was purchased from Peprotech. UT-7/GM cells were
maintained in Iscove’s modified Dulbecco’s medium (IMDM, Invitrogen) supplemented
with 10% fetal bovine serum (FBS, HyClone) and 1 ng/ml GM-CSF. Cell viability was
quantified through Trypan blue (Mediatech) dye exclusion, observed under light
microscope (10x magnification).
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3.2.2. Erythroid differentiation
Recombinant human erythropoietin (Epo) was purchased from AppliChem. To induce
erythroid differentiation, UT-7/GM cells were growth factor starved for 16 hours and
then cultured in IMDM containing 10% FBS and 1U/ml Epo.
3.2.3. Dianisidine staining
Hemoglobin positive cells were identified by incubating cells in serum-free IMDM
medium containing 0.2% 3,3’-dimethoxybenzidine, fast blue B (dianisidine, Sigma),
0.3% acetic acid and 0.3% hydrogen peroxide for 20 minutes at room temperature. Cells
were observed under light microscope (40x magnification) and the cells that stained dark
blue were marked positive for hemoglobin.
3.2.4. Analysis of surface EpoR expression by immunofluorescence
Approximately 1x105 cells were extracted from culture and centrifuged to remove the
medium. Cells were then washed twice with 1xPBS containing 0.5% bovine serum
albumin (PBS-B). Cells were resuspended in 30 μl of PBS-B and incubated with 1 μg of
human IgG antibody (R&D Systems) for 15 minutes at room temperature. Monoclonal
anti-human EpoR antibody conjugated with phycoerythrin (150 ng) was added to the
sample and incubated at 4°C for 45 minutes. Cells were then washed again with PBS-B
and resuspended in 200 μl of PBS-B. The cells were then analyzed for EpoR expression
using a Guava Flow Cytometer.
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3.2.5. Analysis of GATA1 expression by western blotting
Approximately 1x107 cells were extracted and centrifuged to remove culture media. Cells
were then washed with 1xPBS and incubated in 500 μl lysis buffer (Invitrogen)
supplemented with PMSF, protease inhibitors (Sigma) and phosphatase inhibitors
(Sigma) for 30 minutes at 4°C. The samples were centrifuged at 13000 g for 15 minutes
at 4°C. Total protein concentrations in the samples were estimated by BCA protein assay
(Pierce) according to the manufacturer’s instructions. After the addition of 4x reducing
agent (Invitrogen) and 10x sample buffer (Invitrogen), 20 μg of protein sample was
boiled at 95°C for 5 minutes, separated by SDS-polyacrylamide gel electrophoresis (160
volts, 95 minutes, 4°C), transferred onto nitrocellulose membrane (30 volts, 60 minutes,
4°C) and blocked with Odyssey blocking buffer (LI-COR, 60 minutes, room
temperature). The membrane was incubated with rat monoclonal GATA-1 (N6) antibody
from Santa Cruz (sc-265, dilution 1:1000) and then washed five times with 1xPBS
containing 0.2% Tween-20 (Bio-Rad). Lastly, the membrane was treated with rabbit antirat IRdye-800 antibody from Rockland Immunochemicals (612-431-026, dilution
1:15000) for 45 minutes at room temperature. The protein signals were detected using a
LI-COR infrared imager and GATA1 bands were quantified with the analysis software
provided by the manufacturer.
3.2.6. Cell sorting based on surface EpoR expression
Approximately 3x107 cells were extracted from culture, centrifuged to remove medium
and washed with PBS-B. Cells were incubated with monoclonal anti-human EpoR
antibody conjugated with phycoerythrin and prepared for sorting as described in the
88

section 3.2.4. The EpoR-antibody bound cells were resuspended in PBS-B and sorted for
EpoR expression in a Becton Dickinson Digital Vantage cell sorter. EpoR (low, med,
high) cells were classified as being the bottom, middle and top 5% of the unsorted cells,
respectively. The sorted cells were either re-cultured for differentiation experiments or
lysed to extract proteins for GATA1 western blot experiments.

3.3. Results and Discussion
3.3.1. Epo-induced lineage commitment and differentiation
UT-7/GM cells, which are derived from a parental human megakaryoblastic leukemia
cell line (UT-7), have been previously shown to be a successful model system to study
erythrocyte differentiation34,

35

. UT-7/GM is a growth factor dependent cell line and

requires granulocyte-macrophage colony stimulating factor (GM-CSF) for its survival
and proliferation36. The cells remain undifferentiated in the presence of GM-CSF and
erythrocyte differentiation can be induced by replacing GM-CSF with Epo. The
differentiation process closely mirrors that of other human erythrocyte progenitor model
systems. One reason that the dynamics of receptor and transcription factor upregulation
may have been overlooked to date is that a large number of studies have been performed
in mouse models that possess fast differentiation kinetics (~ 2 days). By contrast, human
UT-7/GM cells require two weeks in culture with 1U/ml Epo to reach their differentiation
maximum (as assessed by hemoglobin staining). Figure 3.2A shows UT-7/GM cells
grown in GM-CSF (left panel) and Epo (right panel) for 14 days and stained with
dianisidine, a dye that indicates the presence of hemoglobin (dark blue spots). As seen in
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this figure, Epo-induced cells show hemoglobin synthesis compared to the uninduced
cells.
We performed an Epo-dose response experiment to study the relationship between
Epo induction and hemoglobin production (Figure 3.2B). UT-7/GM cells cultured in
GM-CSF were growth-factor starved for 16 hours, and then cultured in media containing
different concentrations of Epo. The cells were stained with dianisidine, after 14 days of
culture with Epo, to determine the percentage of hemoglobin positive cells. The plot
shows an ultrasensitive, or switch-like, response, where a 10-fold increase in Epo level
(from 0.001U to 0.01U) switches most of the undifferentiated cells to the differentiated
state. This response is much steeper than a graded, hyperbolic response, which requires
an 81-fold increase in stimulus to attain a change in response from 10% to 90%.
Increasing the stimulus over 0.01U did not show significant improvement in
differentiation efficiency. This switch-like response is also consistent with the presence
of positive feedback loops in the differentiation circuitry.
We quantified the percentage of differentiated cells at different time points during
the two-week period with Epo-induction (1U, 0.01U, 0.001U) (Figure 3.2C). The plot
suggests that for Epo concentrations of 1U and 0.01U, the cells remained mostly
undifferentiated for the first 4 days and then showed a linear increase in differentiation
efficiency from day 4 to day 10. This is particular interesting when we compare these
results to the cell viability data for the same time points during differentiation (Figure
3.2D). The profile shows an initial decrease in cell viability, possibly due to the selection
of cells expressing a minimum threshold level of EpoR since Epo signaling is absolutely
necessary for cell survival. The cells appear to recover by day 4, suggesting that lineage90

selection and differentiation are independent events, with selection precedes
differentiation. Compared to cultures with 1U Epo, cultures with 0.01U Epo show
decreased viability during initial selection as well as a lower percentage of hemoglobinpositive cells. Cells cultured at 0.001U show a marked decrease in viability during the
initial selection and fail to recover. Due to the poor viability, these cultures showed a
significantly lower percentage of differentiated cells during the two-week period.
There seems to be a threshold concentration of Epo (0.01U higher bound)
necessary to achieve differentiation of large percentage of cells (approximately 75%).
Since lineage commitment should occur during the initial stages of differentiation, we
devised an experiment to pretreat the cells with a high concentration of Epo (0.01U for 3
or 6 days) and then reduce the Epo concentration to a sub-threshold level for the
remainder of the differentiation period. Pretreated cells achieved a significantly higher
percentage of differentiation when compared to control cells grown at 0.001U Epo
(Figure 3.2E). Cells pretreated for 6 days differentiated better than the 3 day pretreated
cells, but their efficiency was significantly lower than the culture grown at 0.01U. The
corresponding cell viability assay showed that pretreated cells achieved a greater
percentage viability compared to the control cells grown at 0.001U. This experiment
suggests that the initial pretreatment commits cells towards differentiation and that
lowering of Epo concentration did not affect a large percentage of the committed cells as
they retained the memory of high Epo concentration and continued to differentiate.
3.3.2. Synchronous upregulation of GATA1 and EpoR during differentiation
The memory seen during lineage commitment as well as the existence of a switch-like
response (from section 3.3.1) can be due to the presence of the two positive feedback
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loops between GATA1 and EpoR, induced by Epo. It is well recognized that lineagespecific transcription factor expression gets upregulated during differentiation due to the
need to upregulate all lineage-specific genes and to downregulate other lineage-specific
transcription factors. We confirmed the presence of the autofeedback look by showing
the upregulation of total GATA1 during Epo-induced differentiation of UT-7/GM cells
through quantitative western blots (Figure 3.3A). We also quantified cell-surface EpoR
levels from viable cells during differentiation by flow cytometry (Figure 3.3B). EpoR
levels were expected to decrease with Epo-induction since Epo/EpoR complex
endocytosis is much faster than EpoR constitutive endocytosis. Indeed, we noticed an
initial decrease in EpoR expression in the first few hours after Epo induction and the
receptor levels quickly reached steady state (data not shown); however, after 24 hours,
the EpoR levels slowly began to climb and, by day 8, reached a maximum of
approximately 12-fold that of the initial steady-state. This shows that EpoR is
significantly upregulated, confirming the presence of an Epo-induced positive feedback
loop through the receptor during differentiation. This result is interesting, because as seen
from the viability plot (Figure 3.2D), the initial selection happens in the first few days of
differentiation, when the EpoR levels are still low. After selection, the cells should
express enough EpoR to provide survival signals and do not have the need to increase
EpoR expression; hence, the upregulation of EpoR should be an event necessary for
commitment rather than selection.
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3.3.3. Heterogeneity in EpoR and GATA1 expression is positively correlated in
differentiating cells
After establishing the presence of the two positive feedback loops during Epo-induced
differentiation, we wanted to analyze whether EpoR and GATA1 expression are
correlated during differentiation. UT-7/GM cells were induced with Epo and the
heterogeneity in EpoR levels in viable cells was measured by flow cytometry (Figure
3.4A). Histograms show significant broadening on day 2 when compared with the day-0,
day-4 or day-7 populations. This deviation from unimodal distribution in EpoR
expression seems to be driven by Epo and possibly through the two positive feedback
loops that regulate GATA1 and EpoR.
In section 3.3.2, the average expression levels of EpoR and GATA1 were shown
to be positively correlated by synchronous upregulation during differentiation. We
wanted to further analyze whether this correlation existed even within subpopulations of
the same culture on day 2, when a broadening of the EpoR expression histogram was
observed (Figure 3.4A). Cells cultured with Epo for two days were sorted into three
different populations based on the surface EpoR levels – EpoRlow, bottom 5%; EpoRmed,
middle 5%; and EpoRhigh, top 5% of the unsorted cells (Figure 3.4B). The sorted
populations were lysed and the total GATA1 level in each of the populations was
determined through quantitative western blotting. As seen in Figure 3.4C, the sorted
fractions also showed a positive correlation between EpoR and GATA1. This suggests
that EpoR and GATA1 may be part of the same biochemical network, as the change in
GATA1 levels due to the heterogeneity in its expression reflects on EpoR expression.
This shows that cell-intrinsic noise can be transferred to cell-extrinsic components and,
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conversely and perhaps more importantly, extrinsic factors can potentially regulate or
bias intrinsic factors during lineage commitment.
3.3.4. Differential expression of EpoR as a marker for erythrocyte progenitor
commitment
Erythroid progenitors that have committed to differentiate with Epo induction start to
express hemoglobin-synthesizing genes. Synthesis of hemoglobin seems to be preceded
by the upregulation of GATA1 and EpoR. Since EpoR and GATA1 expression are
correlated as shown in Figures 3.3 and 3.4, selecting progenitor cells based on differential
EpoR levels should alter the kinetics of commitment. We sorted day 2 Epo-induced cells
into EpoRlow, EpoRmed and EpoRhigh populations as in section 3.3.3. The sorted
populations were immediately transferred to Epo-containing media to continue the
differentiation program. The surface EpoR level in all three populations was quantified
on day 4 and day 7 and compared to the unsorted population (Figure 3.5A). EpoRlow cells
could not be propagated, likely due to insufficient EpoR signaling for survival.
Comparison of EpoR levels revealed no significant change in the mean between the
unsorted population and the EpoRmed population, whereas the receptor expression level in
the EpoRhigh population was significantly higher than in the other two samples. From the
dianisidine assay, EpoRhigh and EpoRmed populations showed approximately 4.0-fold and
2.5-fold increases in positive cells, respectively, compared to the unsorted population on
day 4 (Figure 3.5B). On day 7, EpoRhigh and EpoRmed populations showed approximately
2.0-fold and 1.6-fold increase in positive cells, respectively, compared to the unsorted
population (Figure 3.5B). This result suggests that progenitor cells expressing high levels
of EpoR are intrinsically primed towards erythrocyte commitment and possess enhanced
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kinetics of differentiation. Hence, due to the positive correlation between GATA1 and
EpoR, differential expression of EpoR in progenitor cells can serve as a marker for
sorting and recovering erythrocyte-committed cells.
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Figure 3.1

Figure 3-1 Positive feedback loops connecting EpoR and GATA1
A model showing the topological connections between EpoR and GATA1: Epo binds to EpoR to
activate signaling pathways that can post-transcriptionally activate GATA1. GATA1 can
upregulate its own inactive form through an autofeedback loops as well as upregulate the
expression of EpoR, thereby enhancing its own activation. The autofeedback loop is intrinsically
regulated, whereas Epo extrinsically regulates the receptor-mediated feedback loop.
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Figure 3.2

Figure 3-2 Epo-induced differentiation of UT-7/GM cells
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(A) Dianisidine staining: Control cells growing in GM-CSF showing no synthesis of hemoglobin
(left panel), Cells induced with Epo (1U/ml) for 14 days showing the presence of hemoglobin
through the dark spots (right panel). (B) Epo dose response curve: Cells were growth factor
starved and treated with different concentrations of Epo and stained with dianisidine after 14
days. Percentage of dianisidine positive cells (presence of hemoglobin) is plotted against Epo
concentration. The plot shows an ultrasensitive, or switch-like, response in differentiation to Epo
concentration. (C) Kinetic of differentiation: Cells were growth factor starved and treated with
1U/ml, 0.01U/ml and 0.001U/ml of Epo and the percentage of dianisidine positive cells were
quantified at different time points during the differentiation period. High percentage of cells with
Epo 1U/ml and 0.01 U/ml differentiated by day 13, whereas cells grown with Epo 0.001 U/ml
remained largely undifferentiated. (D) Cell viability during differentiation: During the
differentiation kinetics experiment in C, differentiating cells were also checked for percentage
viability through Trypan blue dye exclusion assay. Cell viability decreases sharply in the first two
days (~75% for Epo 1U/ml and ~65% for Epo 0.01U/ml) and then recovers to initial levels
(~95%). Cells grown with Epo 0.001 U/ml showed sustained decrease in viability and did not
recover. (E) Pretreatment experiment: Cells were grown with Epo 0.01 U/ml for 3 or 6 days and
then switched to 0.001 U/ml Epo. Cells grown all through with 0.01 or 0.001 U/ml of Epo are
shown as controls. (F) Cell viability during the pretreatment assay: For the data point in E, cells
were also analyzed to quantify the percentage viability.
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Figure 3.3

Figure 3-3 Synchronous upregulation of GATA1 and EpoR
(A) Upregulation of total GATA1: Cell lysates collected at different time points during
differentiation were blotted for total GATA1. The quantified protein bands show an upregulation
in total GATA1 levels. (B) Upregulation of surface EpoR: Cells from differentiating cultures
were treated with monoclonal antibody to EpoR conjugated with phycoerythrin and surface EpoR
levels were quantified by flow cytometry. Surface EpoR levels show upregulation during Epoinduced differentiation.
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Figure 3.4

Figure 3-4 Heterogeneity in EpoR and GATA1 expression is positively correlated
(A) Histograms showing the heterogeneity in surface EpoR expression at different time points
(days 0, 2, 4 and 7) during differentiation. (B) Cell sorting based on surface EpoR expression:
Cells grown in Epo for two days were sorted into three distinct populations: bottom 5%
(EpoRlow), middle 5% (EpoRmed) and top 5% (EpoRhigh). (B) Total GATA1 levels in each of the
three sorted populations were measured by quantitative western blots. The noise in EpoR
expression is correlated with GATA1 levels.
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Figure 3.5

Figure 3-5 Differential expression of EpoR as a marker for progenitor commitment
(A) Surface EpoR expression during differentiation: Sorted populations (EpoRlow, EpoRmed and
EpoRhigh) from Figure 3.4 were immediately re-cultured with Epo (1U/ml). EpoRlow cells could
not be propagated, likely due to the lack of survival signals from Epo. Surface EpoR levels in
EpoRmed and EpoRhigh cells were compared to the unsorted cells on day 4 and day 7. (B)
Hemoglobin positive cells: Percentage of differentiation on day 4 and day 7 from the sorted cells
(EpoRmed and EpoRhigh) were quantified by dianisidine staining and compared to the unsorted
cells.
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Chapter 4
Converting a Linear Signaling Pathway into an ExternallyRegulated, Tunable, and Reversible Switch

4.1. Introduction
In response to extracellular cues, natural biological systems can evoke dynamic internal
responses that can be critical for achieving robust phenotypic changes. Natural systems
can exhibit a wide array of responses with modularity and specificity by integrating
signaling elements at the cell surface, cytoplasm and nucleus. Cell-surface receptors
enable cue-specific recognition and signaling, cytoplasmic messengers provide signal
processing modules and transcriptional elements in the nucleus regulate complex changes
in gene expression. The signal-response circuitry in natural biological systems is
extremely unwieldy due to evolved complexity. Synthetic biology provides a means to
dissect these complex signaling motifs in order to better understand the design principles
underlying the dynamics of a network of interest and, ultimately, the phenotypic
response1-3.
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Synthetic biology as a field possesses tremendous potential4-8 in improving drug
delivery, producing alternative fuels, detecting cancer, engineering tissues, and enhancing
gene therapy; however, it has faced major challenges due to the inefficiency of individual
modules, incompatibility between interacting parts, unpredictability in large circuitry and
inconsistency due to cellular variability9. The solution to some of these drawbacks can
arise from designing generalizable methodologies to invoke specific responses from any
given circuitry with minimal modifications.
Changes in gene expression are fundamental to any phenotypic response and two
molecular components that invariably regulate this process are cell surface receptors and
nuclear transcription factors. These two signaling elements are ubiquitously present in
most natural systems and control survival, apoptosis, proliferation, lineage commitment
and differentiation10-12. Here, we present an externally-regulated autofeedback topology,
inspired from lineage commitment networks in stem cells and progenitors13, 14, which is
capable of converting any linear receptor-to-transcription factor signaling pathway into a
reversible switch.
Most of the synthetic systems developed to date utilize autofeedback loops
activated by membrane diffusible small molecules to achieve a bimodal response15-20.
These systems are typically irreversible and require extensive tuning to achieve the
desired response. In contrast, natural systems can regulate their autofeedback loops
through external ligand and achieve robustness in the exhibited response by incorporating
signaling modules between the receptors and transcription factors. Previously, we
developed a mathematical model of a minimal topology that can generate robust bistable
responses for any linearly connected receptor/transcription factor pair13,

14

. In this
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topology, a ligand binds to its cognate cell-surface receptor and transmits a signal that
activates a downstream transcription factor. The activated transcription factor activates its
own transcription as well as that of the cognate cell-surface receptor. Since the
transcription factor requires a post-transcriptional modification for activation, the
displayed response is reversible and externally regulatable. Furthermore, our synthetic
approach only requires rewiring of existing components (as opposed to introducing new
components), and therefore requires minimal tweaking to achieve a robust response.
As proof of principle, we tested our approach in Saccharomyces cerevisiae using
a pathway that involves synthetic receptor (CRE1 from Arabidopsis thaliana) signaling to
an endogenous yeast transcription factor (SKN7)21. This basic pathway, which is graded
and unimodal, was rationally rewired to achieve our desired topology and the resulting
network immediately showed high ultrasensitivity and bimodality without tweaking. We
further show that this topology can be tuned to regulate system dynamics such as
activation/deactivation kinetics, signal amplitude, switching threshold and sensitivity.

4.2. Materials and Methods
4.2.1. Plasmids
Plasmids and their properties are provided in Table 4.1. E. coli strain XL1-Blue was used
for all plasmid construction. Yeast integration plasmids pRS403 and pRS405 were
purchased from Stratagene. Yeast centromere plasmids DQ232595, DQ232596 and
DQ232600 were kindly provided by Ron Weiss (Massachusetts Institute of Technology).
The SKN7 gene was PCR amplified from the S. cerevisiae genome. Plasmids were
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constructed as follows: for pSP001, DQ232600 was cut with Pvu1 to remove
CEN6/ARSH4 component and ligated into pRS405 digested with Pvu1; for pSP002 and
pSP003, DQ232600 was digested with BamH1 to excise AtCRE1a-PSSRE region and
cloned into DQ232595 and DQ232596. CEN6/ARSH4 and HIS3 component were
removed from the modified DQ232595 and DQ232596 plasmids (Pvu1 site) and ligated
into pRS405; for pSP004, the SKN7 gene was cloned to replace yEGFP3 in DQ232596
using the BamH1/Asc1 restriction sites. The CEN6/ARSH4 component in the modified
DQ232596 vector was removed (Pvu1 site) and ligated into pRS403 plasmid. All plasmid
constructs were verified by sequencing.
4.2.2. Yeast strains, genomic screens and culture
Yeast strains and their properties are listed in Table 4.2. Yeast transformations were
performed using the high-efficiency LiAc/SS carrier DNA/PEG method with the standard
synthetic dropout (SD) media. The no-feedback strain cRcTF was constructed by
integrating a single copy of pSP001 into the LEU2 locus of the TM182 strain. Receptor
feedback strains sRcTF and tRcTF were built by integrating a single copy of pSP002 and
pSP003, respectively, into the LEU2 locus of TM182 strain. The transcription factor
feedback strain cRtTF was constructed by integrating a single copy of pSP004 into the
HIS3 locus of the cRcTF strain. Double feedback strains sRtTF and tRtTF were built by
integrating a single copy of pSP004 into the HIS3 locus of the sRcTF and tRcTF strains,
respectively.

Yeast

genomic

DNA

isolation

was

performed

using

the

phenol:chloroform:isoamyl alcohol (PCI) method. The isolated genomic DNA was
probed for stable single integration of the transformed gene at the desired locus through
PCR.
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The wild-type TM182 strain was used as a negative control in all experiments.
Yeast strains were grown at 30ºC in their respective SD Ura-/His-/Leu- medium with 2%
galactose. IP was purchased from Sigma-Aldrich.
4.2.3. Analysis of GFP expression
For all IP-induction experiments, GFP levels were quantified by fluorescence-activated
cell sorting (FACS) using a Guava flow cytometer containing a 488 nm argon excitation
laser and a 525/30 nm emission filter. For each sample, 10,000 events were acquired and
the fluorescence data was analyzed using FlowJo 7.5.

4.3. Results and discussion
4.3.1. Network design
A cell-surface receptor from A. thaliana has previously been coupled to signaling
components from S. cerevisiae to successfully create a synthetic linear signaling
pathway21. In this work, we have rationally constructed several topological variations of
this pathway to achieve switch-like bimodality in system response, as well as tunability in
set-point, EC50 and ultrasensitivity. Previous work with these signaling elements used
yeast centromere plasmids for pathway construction21. Due to the difference in copy
number of transformed genes in the cells, we observed a high degree of heterogeneity in
the expression of the signaling elements (data not shown). To minimize this variability,
we chose to use yeast integrating plasmids and performed genomic screens to obtain
clones with stable, single integrations of the transformed genes.
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The basic pathway without feedback loops (cRcTF) was created by integrating a
single copy of AtCRE1, an A. thaliana cytokinin receptor gene22, driven by the
constitutive CYC1 promoter and a single copy of yEGFP3, yeast green fluorescent gene
driven by the SSRE promoter. The synthetic SSRE promoter contains the binding site for
the yeast endogenous transcription factor SKN7. The plant cytokinin isopentenyl
adenine23 (IP) was used as the ligand to activate the AtCRE1 receptor. The activated
receptor signals via a yeast endogenous pathway to phosphorylate SKN724, 25. PhosphoSKN7 can bind to the SSRE promoter and activate GFP expression (Figure 4.1).
Networks with only receptor feedback (sRcTF and tRcTF) were created by
replacing the CYC1 promoter of AtCRE1 with SSRE or TR-SSRE (contains two binding
sites for phosphorylated SKN7), thereby creating an IP-regulated positive feedback loop
through the receptor. The network with only transcription-factor feedback (cRtTF) was
created by integrating a single copy of the SKN7 gene, driven by the TR-SSRE promoter,
to the basic pathway. Networks with both receptor and transcription-factor feedback
(sRtTF and tRtTF) were constructed by integrating a single copy of the SKN7 gene
(driven by TR-SSRE promoter) and by replacing the CYC1 promoter of AtCRE1 with
either SSRE or TR-SSRE.
4.3.2. Set-point and synthesis kinetics
Expression of GFP is dependent on the concentration of phosphorylated SKN7 (phosphoSKN7). Synthesis of phospho-SKN7 requires the expression of SKN7 and its subsequent
posttranslational modification via IP:AtCRE1 complex signaling. Hence, the expression
of GFP can be limited either by the insufficiency of SKN7 (transcription factor limited)
or IP:AtCRE1 complex (receptor limited).
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All six strains were grown overnight in their respective SD media to reach steadystate. The cultures were then diluted to an OD660 reading of 0.1 and induced with 1μM IP.
Aliquots from the growing cultures were extracted at different time points to quantify
GFP levels by flow cytometry.
Change in receptor feedback strengths (CYC1, SSRE, TR-SSRE) did not change
the achieved steady-state set-point of GFP when the transcription factor SKN7 was
driven only by the constitutive promoter. This is probably due to the fact that receptor
expression from all the promoters was sufficient to activate the endogenous levels of
SKN7; hence, these systems are transcription-factor limited (Figure 4.2A).
When we added an exogenous copy of the SKN7 gene, driven by a TR-SSRE
promoter, to the network, the system became receptor-limited. Strain cRtTF was most
limited by the synthesis of AtCRE1, which was significantly overcome by replacing the
constitutive CYC1 promoter with SSRE promoter (Figure 4.2B). A further increase in
GFP expression was obtained by switching the SSRE promoter to the stronger TR-SSRE
promoter (Figure 4.2B). In contrast to the strains with constitutive (and limiting)
expression of SKN7 (cRcTF, sRcTF and tRcTF), strains cRtTF and sRtTF are limited by
the synthesis of AtCRE1.
Also, the kinetics of production of GFP seems to vary based on the network
topology due to the variation in the rate of synthesis of Phospho-SKN7. In Figure 4.2C,
the kinetic profiles of all the strains were normalized to their steady-state value. The
strain with the basic pathway is the fastest to reach steady-state (60% level is reached
around ~4 hours), followed by the receptor-feedback strains (60% level in ~5 hours for
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sRcTF and ~ 6 hours for tRcTF). The transcription-factor feedback strain and sRtTF
double feedback strain reached 60% level ~ 7.5 hours; whereas the tRtTF strain was the
slowest and attained the 60% mark ~ 9 hours post IP-induction.
This shows that by operating the system with different strengths of feedback at
the transcription factor and receptor level, we can achieve tunability in the steady state
set-point as well on the time to reach steady-state.
4.3.3. Ultrasensitivity and EC50
All six strains were grown overnight in their respective SD medium and then diluted back
to an OD660 of 0.1 and induced with different concentrations of IP spanning from 0.01 to
10 µM. The steady-state levels of GFP were plotted against IP concentration to analyze
the dynamics of the response. We noticed that the basic pathway and the networks with
only receptor-mediated feedback showed a graded response with respect to IP
concentration, whereas the strains with transcription-factor feedback and with both
feedback loops showed a highly switch-like response to change in IP (Figure 4.3). No
feedback and receptor feedback strains reached set-point saturation around 1 µM IP,
whereas the other three strains reached saturation at 10-fold lower IP (Figure 4.3).
The steady-state dose-response curves show that the ultrasensitivity was lowest in
the no-feedback (Hill coefficient ~2) and receptor-feedback networks (Hill coefficient
~2), significantly higher in the transcription-factor-feedback network (Hill coefficient
~11) and, higher still in the double-feedback networks (Hill coefficient ~24). Also, the
networks with transcription-factor feedback and double feedback showed 2-fold lower
EC50 when compared with no feedback and receptor-feedback networks (Figure 4.3).
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This shows that the basic pathway in this system is ultrasensitive and its
sensitivity can be increased by the incorporation of transcription factor feedback, and
further improved by the addition of receptor-feedback loops. Also, with feedback loops,
the system can be tuned to switch on at lower IP concentrations than those that activate
the basic pathway.
4.3.4. Bimodality and degradation kinetics
Degradation kinetics for the no feedback control strain cRcTF and double feedback strain
tRtTF were compared in Figure 4.4A. The two strains were grown in 1 µM IP for 24
hours to achieve saturated levels of GFP. The cells were then spun down, washed three
times with regular media and cultured in their respective SD media without IP. Aliquots
from the cultures were extracted and quantified for GFP levels. The figure shows that
both systems are reversible and therefore ultimately shut off; however, there is a delay in
the degradation kinetics of tRtTF when compared to cRcTF (Figure 4.4A). This could
possibly be due to the higher accumulation of phospho-SKN7 in tRtTF than in cRcTF at
steady state. Another possible explanation is that, due to the higher cell-surface receptor
expression on the cells with receptor feedback, more residual IP may be bound on tRtTF
cells than on cRcTF cells.
When IP was only reduced to a sub-threshold concentration (rather than
completely removed), the degradation kinetics of the GFP signal became markedly
different between the two strains. When IP was lowered to 0.025 μM, the tRtTF strain
retained ~50% of its maximal response after 10 hours whereas the cRcTF strain only
sustained ~10% of its response (Figure 4.4B). When IP was lowered to 0.05 μM, the
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tRtTF strain sustained ~70% of its response but the cRcTF strain only retained ~10% of
its maximal response (Figure 4.4C). This shows that the tRtTF topology confers memory
to the cell with respect to the receptor-specific ligand (here, IP). The initial induction
with high IP triggers this memory, which helps to sustain the response even after
lowering the IP to sub-threshold levels. We analyzed the GFP histograms from time
points in Figure 4.4C. As seen from the plot, the entire histogram for the cRcTF strain
shifted to lower mean fluorescence at each time point when a step change in IP (from 1
µM to 0.05 µM) was introduced into the system (Figure 4.4D). This shows a typical
monostable response, as each cell with the basic pathway lost its fluorescence gradually
over time once the IP concentration was lowered. By contrast, the tRtTF strain showed
bimodality in GFP expression as the IP concentration was lowered to 0.05 μM; a high
percentage of cells remained in the high-GFP state and a low percentage of cells
completely lost their fluorescence, with virtually no cells exhibiting intermediate
fluorescence intensities (Figure 4.4D). The aggregate decrease in fluorescence of a
population of tRtTF cells does not result from a decrease in the mean fluorescence
intensity of the overall population but, rather, from a shift in the relative populations of
the high-GFP and low-GFP states.
In conclusion, we have presented here a method by which any linear signaling
pathway with incorporation of two positive feedback loops can be rewired to exhibit a
bimodal response. This system is completely reversible and by changing the strengths of
the feedback loops, we show tunability in kinetics, set-point, EC50 and ultrasensitivity.

114

Figure 4.1

Figure 4-1 Network design
Plant cytokinin IP binds and activates the plant receptor AtCRE1. Signaling from this receptor
results in phosphorylation of the yeast endogenous transcription factor SKN7. Phospho-SKN7
binds to synthetic promoters SSRE and TR-SSRE and expresses the downstream genes. AtCRE1
is either expressed constitutively or expressed via SSRE or TR-SSRE promoters to form a
receptor feedback loop. SKN7 is expressed constitutively and in some networks, an additional
copy is regulated through the TR-SSRE promoter to form an autofeedback loop. GFP is only
expressed through the SSRE promoter.
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Figure 4.2
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Figure 4-2 Variation in set-point and synthesis rate of GFP
All strains were grown in 1 µM IP until GFP levels reached saturation. Aliquots from the cultures
at different time points were taken to determine the synthesis kinetics of GFP (A) Expression of
GFP limited by transcription-factor expression: Kinetic profiles of strains with variable strength
of receptor feedback loop and constitutive expression of transcription factor. AtCRE1 receptor
expression from cRcTF, sRcTF and tRcTF strains were sufficient to activate the endogenous
levels of SKN7. (B) Expression of GFP limited by receptor expression: Kinetic profiles of strains
with variable strengths of receptor feedback loop and autofeedback driven expression of
transcription factor. When an additional copy of SKN7, driven by the TR-SSRE promoter, was
added to the system, the strains cRtTF and sRtTF became receptor limited. (C) Kinetic profiles of
the strains are normalized to their steady-state set-point. All six strains achieve steady-state at
different times; cRcTF seems to be the fastest and tRtTF the slowest.
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Figure 4.3

Figure 4-3 Tunability of set-point, EC50 and ultrasensitivity
All six strains were grown at different IP concentrations spanning from 0.01 µM to 10 µM.
cRcTF, sRcTF and tRcTF showed graded responses to changes in IP, whereas cRtTF, sRtTF and
tRtTF exhibited switch-like responses. Also, cRcTF, sRcTF and tRcTF, when compared to
cRtTF, sRtTF and tRtTF, needed two-fold higher IP to achieve the half-maximal response and
10-fold higher IP to achieve the full response.
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Figure 4.4
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Figure 4-4 Degradation kinetics and bimodality
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Strains cRcTF and tRtTF were grown in their respective SD media with 1 µM IP for 24 hours.
After reaching saturation in GFP set-point, the cultures were washed and moved into media with
different sub-threshold IP concentrations: (A) IP = 0, both the strains show reversibility by
switching off GFP expression; however, the degradation kinetics of tRtTF are slower than those
of cRcTF. (B) IP = 0.025 µM, after 10 hours, tRtTF sustained ~50% of maximal response,
whereas cRcTF managed only ~10%. (C) IP = 0.05 µM, after 10 hours, tRtTF retained ~70% of
its steady-state response, whereas cRcTF managed only ~10%. (D) Histograms of GFP
expression from (C) at time points 0, 4.5 and 10 hours. Strain cRcTF shows a unimodal response,
whereas tRtTF shows a bimodal response.
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Table 4.1
Table 4-1 Plasmids used in this study

1.

Chen, M.T. & Weiss, R. Artificial cell-cell communication in yeast Saccharomyces
cerevisiae using signaling elements from Arabidopsis thaliana. Nature biotechnology 23,
1551-1555 (2005).
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Table 4.2
Table 4-2 Yeast strains used in this study

1.

Maeda, T., Wurgler-Murphy, S.M. & Saito, H. A two-component system that regulates
an osmosensing MAP kinase cascade in yeast. Nature 369, 242-245 (1994).
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Chapter 5
Integrating Extrinsic and Intrinsic Signals into a Multilineage
Cell-Fate Model
(Adapted from Palani S. and Sarkar C.A. Integrating Extrinsic and Intrinsic Cues into a
Mininal Model of Lineage Commitment for Hematopoietic Progenitors (2009) PLoS
Computational Biology, September 2009, Volume 5, Issue 9, e1000518)

5.1 Introduction
Multipotent stem cells have the ability to both self-renew and differentiate, thus
sustaining the stem cell pool and giving rise to mature, specialized cells, respectively.
The hematopoietic stem cell (HSC), located in the adult bone marrow, is well
characterized and has served as a popular model system for understanding self-renewal,
lineage commitment, and differentiation1. HSCs are responsible for producing the entire
repertoire of blood cells through the process of hematopoiesis. During hematopoiesis,
HSCs lose the capacity to self-renew and differentiate into common myeloid (CMP) and
common lymphoid (CLP) progenitors2, 3. Multipotent progenitors undergo further
lineage-restricted differentiation to give rise to mature cells via bipotent progenitors. In
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addition to this classical commitment paradigm in hematopoiesis, alternative pathways
are emerging. For example, it has also been observed that HSCs and multipotent
progenitors can bypass canonical intermediate states during commitment4, 5. The exact
molecular events that direct lineage commitment at the stem cell stage or at the
multipotent progenitor level remain elusive, but it is well appreciated that lineage-specific
transcription factors and cytokine receptors play critical roles.
Lineage-specific transcription factors have been identified as master regulators of
commitment and differentiation. They drive the expression of pertinent lineage-specific
genes, thereby initiating the phenotypic change in the progenitor cell down a specific
differentiation path6, 7. Developmental potency of a multipotent progenitor is reflected by
the co-expression of multiple lineage-specific transcription factors at low levels, a
phenomenon known as transcriptional priming8. This promiscuous gene expression
pattern in the progenitor cell necessitates that, during cell differentiation, a specific
transcription factor is upregulated, chiefly by positive autoregulation9,

10

, and other

lineage transcription factors are downregulated, primarily through cross-antagonism11-13.
In addition to lineage-specific transcription factors, cell differentiation is also
believed to be tightly regulated by cytokines. Cytokines signal via their cognate receptors
whose cytoplasmic domains activate various pathways involved in survival, proliferation,
and differentiation14-16. It has been extensively debated whether cell fate during
differentiation is a stochastic or an instructive process. The stochastic theory claims that
the differential expression of lineage-specific transcription factors due to intrinsic noise
in progenitor cells dictates the commitment decision17-19, whereas the instructive theory
argues that the absolute dependence on lineage-specific cytokine receptor signals during
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differentiation shows that cell-fate decisions are regulated by extrinsic growth factor
cues20, 21. An underlying question evoked by both of these theories is whether cytokines
provide instructive cues or select lineage-committed progenitors by providing permissive
survival and proliferation signals. The instructive model does not account for the
occurrence of certain mature cell types even when their lineage-specific receptors are
knocked out. The predetermined distribution of the heterogeneous progenitor population
into mature cells, as suggested by the stochastic model fails to explain how specific cell
types can be enriched during stress or how homeostasis is restored after infections or
therapy. A recent groundbreaking study utilizing bioimaging techniques at the single-cell
level suggests that there is validity to both of these theories20. These authors showed that
lineage-specific cytokines can strongly instruct lineage choice, although differentiation
was still possible in the absence of lineage-specific cytokines.
A more comprehensive understanding of lineage commitment may emerge by
analyzing the biochemical associations that coordinate cell-extrinsic and cell-intrinsic
events. The promiscuous gene expression pattern during differentiation is observed not
only in lineage-specific transcription factors, but also in lineage-specific receptors. A
critical commitment signal during differentiation is the upregulation of the transcription
factor, which aids in expressing the lineage-specific genes; however, the need to
upregulate the lineage-specific receptor, an event also integral to commitment, is still
unclear. This is particularly confounding since the low number of lineage-specific
receptors present in a progenitor cell is sufficient for providing permissive survival cues.
During lineage commitment, the expression of the cytokine receptor mirrors the
expression of the transcription factor, often due to the presence of transcription factor
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binding domains in the promoter region of the receptor gene22-25. The advantage of
regulating the lineage-specific receptor expression through the lineage-specific
transcription factor is not apparent. Recent biochemical evidence also suggests that
cytokines can provide signals to functionally activate lineage-specific transcription
factors through post-translational modifications26 and can also regulate the expression of
transcription factors during cell differentiation27.
Cell differentiation is believed to be an all-or-none "switch-like" event rather than
a gradual transition of a precursor cell to a stable, mature cell. Mathematical modeling
and analysis have been successfully used to provide insights into the biological networks
that give rise to such switch-like behaviors28. Typically, the networks involved in lineage
specification seem to engender cellular memory through nonintuitive behaviors, such as
bistable response profiles. The components that generate bistability, the toggling of the
system between two stable steady states, include nonlinear feedback loops29, 30, external
noise31, and multi-site covalent modifications32. Previous lineage commitment models
have suggested that transcriptionally primed multipotent progenitors are capable of
exhibiting bistability purely via cell intrinsic events of autoregulation and crossantagonism33, 34, but these models have assumed the existence of cooperative positive
feedback loops to achieve bistability and do not consider the role of extracellular cues.
While cooperativity is a widely recognized biological mechanism that may play
an important role in lineage commitment, alternative mechanisms can generate similar
switch-like behavior in networks where cooperativity has not been observed. For
example, we have previously shown that cytokine-regulated, positive feedback of
receptor can generate robust bistability to stimulus without cooperativity in a
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deterministic model for unilineage commitment35 (Chapter 2). Furthermore, even in
networks with cooperativity, receptor-mediated feedback may provide additional
robustness to the system behavior and, perhaps more importantly, offer an external mode
of regulation of cell-fates.
Here, we present a minimal model that integrates the bidirectional regulation
between lineage-specific cytokines and transcription factors with previously explored
autofeedback loops and cross-antagonism to understand the interplay between cellextrinsic and cell-instrinic factors in fate decisions of hematopoietic progenitors. The
model is formulated under the premise that cell-fate decisions are stochastic in nature, but
external cues such as lineage-specific cytokines can heavily bias this stochasticity,
effectively instructing lineage choice (as has now been experimentally observed). Our
model shows that the strength of cross-antagonism can be a critical determinant in
achieving multistability. The analyzed network exhibits a “bilayer” of memory with
respect to external stimuli to provide robustness to both the bipotent and committed
states. The model suggests that noise in the network can enable stochastic switching
between the stable states; however, the distribution of the uncommitted population among
the various states during differentiation can still be strongly biased by external cues.
Furthermore, this modeling framework captures both classical and alternative modes of
lineage commitment seen in hematopoiesis. Although discrete cell fates are likely to
represent high-dimensional attractors36, our minimal model may provide an initial step
towards understanding how extrinsic factors integrate with intrinsic factors and may
elucidate new mechanisms that underlie cell-fate decisions.
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5.2. Methods
5.2.1. Deterministic model
The minimal model shown in Figure 5.1 represents a regulatory network for lineage
commitment of a multipotent progenitor to lineages A and B. The multipotent progenitor
expresses basal levels of both lineage-specific transcription factors TFA and TFB (present
in their inactive forms ITFA and ITFB) and lineage-specific receptors RA and RB before
the addition of ligand. Addition of LA to the system leads to receptor-ligand complex CA
formation. Complex CA activates signaling pathways that lead to the activation of ITFA to
form ATFA. Even though a mechanistic understanding of how this occurs via cytokinemediated signaling has not fully emerged, we have modeled it to be rapidly regulated at
the protein level (e.g., by post-translational modification). There may be other
mechanisms involved (e.g., transcriptional and translational regulation) that are not
considered here. The activated form of the transcription factor, ATFA, upregulates the
transcription of its own gene through positive autoregulatory feedback loop, enhancing
production of ITFA. ATFA also upregulates the expression of the lineage-specific receptor
RA forming a ligand-regulated positive feedback loop. The model also accounts for basal
synthesis of RA and ITFA, degradation of RA, CA, ITFA and ATFA and inactivation of
ATFA (not explicitly shown in Figure 5.1). For simplification, we consider the network
topology in the commitment of the two lineages to be symmetric: the reactions involved
in the activation of ITFB to ATFB by ligand LB and the formation of the two positive
feedback loops are analogous to those described in lineage A. To account for the crossantagonism between the transcription factors TFA and TFB, ATFA and ATFB are modeled
to downregulate the induced expression of [ITFB, RB] and [ITFA, RA] by competitively
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inhibiting the binding of ATFB and ATFA to the regulatory domains present upstream of
their lineage-specific receptor and TF genes. This multilineage commitment network led
to a deterministic model with eight ordinary differential equations (ODEs) as shown in
Table 5.1. The initial conditions and the values of the rate constants are provided in Table
5.2. A single-compartmental homogenous system is assumed and the pathways involved
in TF activation and in the synthesis of TF and receptor are lumped as single-step
reactions.
5.2.2. Stochastic version of the deterministic model
The Gillespie stochastic algorithm was employed to simulate a stochastic version of the
ODE model37. The stochastic reactions and their probability functions are given in Table
5.3. Conversion of the deterministic model to its stochastic form was performed by using
composite Michaelis-Menten type rate expressions in the propensity function instead of
decomposing the minimal model into a series of elementary reactions; this was done to
directly compare the dynamics of both the approaches38, 39.
The probability functions and reactions for the stochastic model are provided in
Table 5.3. The model was run either from the uncommitted state or from the bipotent
state to reach the committed state. The initial conditions for both starting states are also
provided in Table 5.2.
To achieve values close to the true stable steady states, the simulations for both
the deterministic and the stochastic models were run for 100,000 mins or ~70 days. As an
example, for one representative set of parameter values, the deterministic model reached
99% of its 100,000-minute value at approximately 2500 mins. Thus, even for conditions
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that took significantly longer to reach steady state, our simulation time was more than
sufficient. Also, since the time point that we picked is arbitrary, we performed 100
repetitions for each simulation condition to account for random fluctuations. Around this
time point, the noise distribution had low variance and was relatively constant.
Small perturbations in the initial conditions for active species have no effect on
the steady-state values or the distribution among the final states. Large perturbations also
have no effect on the steady-state values, but can significantly alter the final-state
distribution by priming the system with active receptors and/or transcription factors.
Parameters used to generate Figure 5.5
All simulations were started from the uncommitted state with LA|LB values of 0|350,
100|250, 175|175, 250|100 and 350|0.
Initial conditions of the reactants:
[RA]0 = 10; [RB]0 = 10; [CA]0 = 0; [CB]0 = 0; [ITFA]0 = 10; [ITFB]0 = 10; [ATFA]0 = 0; [ATFB]0 = 0

For no inhibition condition: KIA = KIB = ∞
For moderate inhibition condition (in molecules): KIA = KIB = 400
For strong inhibition condition (in molecules): KIA = KIB = 50
All other parameter values are given in Table 5.2. For each condition, the simulations
were run for 100,000 minutes and repeated 10,000 times.
Parameters used to generate Figure 5.6
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All simulations were run using the moderate inhibition condition (in molecules): KIA = KIB
= 400

Initial conditions of the reactants starting from the uncommitted state:
[RA]0 = 10; [RB]0 = 10; [CA]0 = 0; [CB]0 = 0; [ITFA]0 = 10; [ITFB]0 = 10; [ATFA]0 = 0; [ATFB]0 = 0

Initial conditions of the reactants starting from the bipotent state:
[RA]0 = 30; [RB]0 = 30; [CA]0 = 125; [CB]0 = 125; [ITFA]0 = 6; [ITFB]0 = 6; [ATFA]0 = 273;
[ATFB]0 = 273

LA|LB values for different trajectories:
Uncommitted to committed A – 250|5
Uncommitted to committed B – 5|250
Uncommitted to bipotent – 250|250
Bipotent to committed A – 250|5
Bipotent to committed B – 5|250
All other parameter values are given in Table 5.2. For each condition, the simulations
were run for 100 hours and repeated 100 times.
Parameters used to generate Figures 5.7B and 5.7C
All simulations were started from the uncommitted state with LA|LB values of 175|175.
Initial conditions of the reactants starting from the uncommitted state:
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[RA]0 = 10; [RB]0 = 10; [CA]0 = 0; [CB]0 = 0; [ITFA]0 = 10; [ITFB]0 = 10; [ATFA]0 = 0; [ATFB]0 = 0

For moderate inhibition condition (in molecules): KIA = KIB = 400
For strong inhibition condition (in molecules): KIA = KIB = 50
All other parameter values are given in Table 5.2. For each condition, the simulations
were run for 100,000 minutes and repeated 200 times.
5.2.3. Computational methods
The ODE-based deterministic model was solved using the numerical stiff solver ode15s
in MATLAB (The Mathworks, Natick, MA). Time course, steady-state response and
multistability plots were also created using MATLAB. The Gillespie algorithm for the
stochastic model was programmed in C++. Histograms, phase plots and time trajectories
of the stochastic simulations were created using the open-source statistical package R.
5.2.4. Microarray analysis
Normalized microarray data were generously provided by Tariq Enver (University of
Oxford)40. The detailed experimental procedures for the microarray experiments and
analyses are provided elsewhere40. EPOR, GCSFR and TPOR mRNA levels extracted
from the data were further normalized to their basal levels present in the uninduced
FDCP-mix. The inherent heterogeneity in the differentiating populations at each time
point was overcome by weighting the contribution of each cell population to the average
expression of the gene of interest.
Cell samples collected from FDCP-mix cells that were induced to differentiate
along neutrophil, erythrocyte, and megakaryocyte lineages are inherently heterogeneous.
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To overcome the problem of analyzing aggregate microarray data from these samples, we
performed a simple deconvolution by generating a weighting function to account for the
non-uniform contribution from each sub-population to the average signal. This is possible
since the population fractions at each time point for each sample were previously
determined.
Weighting function:

wBi×fB + wNi×fN + wEbi×fEb + wEri×fEr + wMi×fM
B – blast (CMP)
N – neutrophil
Eb – erythroblast
Er – erythrocyte
M – megakaryocyte

wBi – contribution of blasts to the expression of gene i
fB – fraction of blasts in the population
wNi – contribution of neutrophils to the expression of gene i
fN – fraction of neutrophils in the population
wEbi – contribution of erythroblasts to the expression of gene i
fEb – fraction of erythroblasts in the population
wEri – contribution of erythrocytes to the expression of gene i
fEr – fraction of erythrocytes in the population
wMi – contribution of megakaryocytes to the expression of gene i
fM – fraction of megakaryocytes in the population
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The weighted parameters (wXi) were obtained from a global fit to the microarray
data for all time points across all experiments using a least squares approach and are
listed in the Table 5.4. The kinetic expression profile of each gene for each lineage was
then obtained by only considering blasts and the cells that are pertinent to the lineage of
interest.
For erythrocytes: blasts, erythroblasts and erythrocytes
For megakaryocytes: blasts and megakaryocytes
For neutrophils: blasts and neutrophils
After removing the fractional contribution of cells from other lineages, the remaining
populations were normalized to obtain a total fraction of 1.

5.3. Results
5.3.1. Model formulation
Different cell states in our model are identified by the relative expression levels of
lineage-specific receptors and transcription factors. An uncommitted (or 'off-state') cell,
such as a common myeloid progenitor (CMP), is one that expresses lineage-specific
receptors and transcription factors for multiple lineages at low levels. It is primed to
differentiate into several lineages, but not yet committed to any specific lineage. A
bipotent (or 'intermediate-state') cell, such as a megakaryocyte-erythrocyte progenitor
(MEP), is one that is restricted to exactly two lineages, but not yet committed to either of
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them. Lineage-specific receptors and transcription factors for the two lineages are
expressed at intermediate levels. A committed (or 'on-state') cell, such as a
proerythroblast, is one that expresses the receptor and transcription factor of a single
lineage at a high level and will eventually terminally differentiate into the corresponding
mature cell.
The topology of our minimal model for multilineage commitment was informed
by various experimental studies on lineage-specific receptors and transcription factors.
The cytokines Epo, Tpo, GCSF, and MCSF have been shown to offer instructive cues to
uncommitted and bipotent cells to differentiate into committed cells, which then
terminally differentiate into erythrocytes, megakaryocytes, neutrophils, and macrophages,
respectively. Lineage-specific transcription factors GATA-1, PU.1, T-bet, and GATA-3
orchestrate the differentiation program of erythrocytes, neutrophils, Th1, and Th2 cells,
respectively, by regulating the expression of their lineage-specific genes. Transcription
factors GATA-1 and PU.1 have been shown to autoregulate their gene expression by
binding to the promoter region of their own genes. Erythrocytic transcription factor
GATA-1 has been shown to transactivate the Epo receptor (EPOR) gene and the
neutrophilic transcription factor PU.1 has been observed to regulate the expression of the
GCSF receptor (GCSFR). A transcription factor can prevent another transcription factor
from binding to DNA either by competitively binding to response elements (as in the case
of GATA-1 and GATA-2) or by binding to the DNA-binding domain of the transcription
factor itself (for example, GATA-1 and PU.1).
The topology shown in Figure 5.1 represents a generalized minimal network of
these observed connections between the cytokine and lineage-specific transcription factor
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during lineage commitment. The model assumes that the fate decision of an uncommitted
cell to either lineage A or lineage B is determined solely by the concentrations of the
active forms of the respective lineage-specific transcription factors, ATFA and ATFB. The
components that drive the formation of each ATF are the inactive transcription factor
(ITF), which serves as the substrate, and the ligand (L)-receptor (R) complex (C), which
serves as the enzyme. The strong upregulation of ATF during lineage commitment is
achieved through two positive feedback loops that upregulate ITF and R, respectively.
Transcription factor feedback is a cell-intrinsic autofeedback loop and receptor feedback
is an externally (ligand) regulated positive feedback loop. F1A and F2A (expressed in
molecules/min) denote the strengths of the transcription factor and receptor feedback
loop for lineage A, respectively; F1B and F2B represent the corresponding feedback
strengths for lineage B. During commitment, a lineage-specific transcription factor gets
upregulated and other lineage transcription factors get downregulated due to crossantagonism. The mechanism of cross-antagonism between the transcription factors is
modeled to be competitive inhibition in binding to response elements present upstream of
the transcription factor and receptor genes, thereby affecting the strengths of the two
positive feedback loops. While cell fates are likely to represent high dimensional
attractors and this higher level of complexity is not considered here, our minimal model
framework may be useful in elucidating the interplay among extrinsic and intrinsic
factors in lineage commitment and differentiation. The deterministic (ordinary
differential equations) and the stochastic (probability functions) versions of the model
along with the kinetic parameters and initial conditions are provided in Tables 5.1-5.3.
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5.3.2. Double positive feedback loops, coupled with moderate transcriptional crossantagonism, can lead to multistability
To explore the role of the two positive feedback loops in lineage commitment, we first
considered the case with no competitive inhibition between the transcription factors. The
inhibitor dissociation constants KIA (inhibitory effect of A on B) and KIB (inhibitory
effect of B on A) are kept infinite. Figure 5.2A shows the steady-state values of ATFA as
the strength of two autofeedback loops, F1A and F1B, are changed. The strengths of the
receptor-mediated feedback loops and the ligand levels are kept constant (F2A = F2B = 3
molecules/min, LA = LB = 100 molecules). We can see that the system rests in the
uncommitted state when F1A = 0 for the chosen F2 and L values. As we increase F1A, the
system switches to the on-state (committed state) for lineage A. Since, F1 constitutes the
strength of the autofeedback loop in A, increasing F1A over the threshold value will
increase the set point of ATFA in the on-state, provided F2A is not limiting. To consider
the effect of receptor-mediated feedback on the steady-state values of ATFA, the strength
of the autofeedback loops and ligand are kept constant (F1A = F1B = 3 molecules/min, LA
= LB = 100 molecules). Similar to F1A, there seems to be a critical value for F2A at which
the system switches to the on-state (Figure 5.2B). As F2 controls the activation loop,
increasing F2A beyond the critical level will not change the on-state set point value of
ATFA, provided F2A is not limiting. As expected, F1B and F2B have no effect on ATFA
since we have assumed no crosstalk between the two pathways.
The above analysis was repeated with moderate inhibition (KIA = KIB = 400
molecules). Similar to the no inhibition case, there appear to be critical values for F1A and
F2A at which the system switches to the on-state (Figures 5.2C and 5.2D). However,
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increasing F1B and F2B increases the switching values of F1A and F2A, due to the negative
feedback from ATFB on ATFA. It is interesting to note that for high values of F1B and F2B,
the system reaches a stable, intermediate state at which the concentration of ATFA is
higher than that in the uncommitted state, but less than that in the committed state (by
symmetry, the same effect is observed for ATFB; see Figure 5.3). As in the committed
state, the set point in this intermediate state increases with F1, but not with F2. To better
visualize the intermediate state, cross-sections of F1B and F2B from Figures 5.2C and 5.2D
for various values of F1A and F2A are given in Figures 5.2E and 5.2F, respectively. For
strong inhibition (KIA = KIB = 50 molecules), the system achieves commitment to lineage
A for F1A and F2A values above the threshold levels. When F1B and F2B are increased over
the critical value, the system requires concomitantly larger increases in F1A and F2A
values to switch from the uncommitted state compared to the moderate inhibition
condition (Figures 5.2G and 5.2H). Also, strong mutual inhibition between the
transcription factors destroys the stable intermediate state, so the cells can rest only in the
uncommitted or committed state. Since the model is symmetric with respect to lineages A
and B, the steady-state responses of ATFB with respect to changes in F1 and F2 are
analogous to the results shown for ATFA (see Figure 5.3). It should be noted that the
system is capable of achieving multistability for a given F1 and F2 (results not shown);
however, only the stable solution attained without the memory of strong feedback (i.e.,
the simulations were always started from the off-state) is plotted in Figure 5.2.
5.3.3. “Bilayer” memory in a tristable system
External regulation provides a practical way to control the dynamics of the network
without the need to alter the internal control elements of the system. We analyzed how
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cell commitment might be influenced in the presence of conflicting ligands with the
strength of the positive feedback loops held constant (F1 = F2 = 3 molecules/min) for the
moderate inhibition case. As seen from the phase plots in Figure 5.4, increasing LA for
low LB cases commits the uncommitted cell to lineage A (red region in Figure 5.4A),
increasing LB for low LA commits the cell to lineage B (red region in Figure 5.4B), and
for high values of both LA and LB the system rests at a third, bipotent state that is primed
but not committed to either of the lineages (overlapping yellow regions in Figures 5.4A
and 3B). For low LA and LB (both less than ~40 molecules), the system remains in the
uncommitted state (overlapping blue regions in Figures 5.4A and 5.4B).
To explore the robustness of the bipotent and committed states, we tested the
system for memory to external stimulus. From the phase plots, we chose LB = 300 to
analyze the robustness of the bipotent state. The steady-state response plots of ATFA and
ATFB for LB = 300 are given in Figures 5.4C and 5.4D. In Figure 5.4C, increasing LA
switches the system from the committed B state to the bipotent state (solid red line). After
reaching the bipotent state, the ligand concentration can be decreased far below the initial
switching concentration while still maintaining the system in the bipotent state (dotted
red line). However, complete removal of LA switches the system back to the committed B
state. For the ligand concentrations spanned by the dotted red line, the system is bistable.
Considering the steady-state response of ATFB in the same simulation, we see that for
low LA values, the system is already committed to lineage B (Figure 5.4D). However,
increasing LA can decommit the cell to a bipotent state (solid blue line). Decreasing LA
after reaching the bipotent state maintains the cell in that state for values of LA much
lower than the decommitment concentration (dotted blue line). So, the system is also
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bistable for ATFB expression (inversely correlated to ATFA expression) and can exist
either in the committed state for lineage B or in the bipotent state based on the memory of
LA.
To analyze the switching of the system across three states, we chose LB = 100
based again upon the phase plots in Figures 5.4A, B. In Figure 5.4E, a modest increase in
LA switches the system to the bipotent state and a further increase in LA, switches the
system to the committed A state (solid red line). If the ligand concentration is lowered
after the system reaches either the bipotent state or the committed state, the system
remains in the current state (dotted and dot-dash red lines). This hysteresis is greater for
the committed state than for the bipotent state, suggesting that the committed state is
more robust to changes in the ligand concentration. For LB = 100 and for 10 < LA < 75,
the system exhibits tristability (i.e., it can exist in committed state A, committed state B,
or the bipotent state). The steady-state response plot of ATFB for LB = 100 (Figure 5.4F)
shows that a committed B cell decommits to the bipotent state and then further to lineage
A with an increase in LA (solid blue line). As in Figure 5.4E, the bipotent and lineage A
states are robust with respect to decreases in LA (dotted and dot-dash blue lines) and the
system exhibits tristability for the same concentration range of LA as in Figure 5.4E. It
should also be noted that the ligand-dependent multistability seen for a lineage-specific
transcription factor is the same for the corresponding lineage-specific receptor, thus
simultaneously generating memory in cell-extrinsic and cell-intrinsic signals.
5.3.4. Extrinsic cues can regulate stochastic switching
We developed a stochastic version of the ordinary differential equation (ODE)-based
deterministic model to analyze how noise in the network might affect the fate decision of
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an uncommitted cell (i.e., one that initially contains no ATFA or ATFB) and how external
signals might regulate these stochastic transitions. The stochastic model was initialized
with several LA|LB combinations (0|350; 100|250; 175|175; 250|100; 350|0) for the no
inhibition, moderate inhibition, and strong inhibition conditions. In each of 10,000
simulations, the system was allowed to reach steady-state and steady-state ATFA and
ATFB levels for the first three ligand combinations listed above are shown as 3D
histograms in Figure 5.5 (since the model is symmetric, the 250|100 and 350|0 plots are
virtual mirror images of the 100|250 and 0|350 plots, respectively, in Figure 5.5). Unlike
the deterministic model, which only provided a population average of the four attainable
steady states (uncommitted, bipotent, lineage A, lineage B) for any LA|LB, the stochastic
simulations elucidated the relative populations of these multiple steady states for a given
LA|LB. For the no inhibition condition, an uncommitted cell can reach any of four distinct
stable states given the appropriate extracellular cues: uncommitted, A, B, and a
committed AB state with high ATFA and ATFB values (though this last state is simply a
consequence of having no inhibition and likely has little relevance in biological
mechanisms specific to cell commitment decisions). When ATFA and ATFB can
moderately inhibit each other, the uncommitted, A, B, and bipotent states can all be
populated, even for a single LA|LB combination (e.g., middle plot in Figure 5.5).
However, when the transcription factors exhibit strong cross-antagonism, this bipotent
state is no longer realizable and cells only commit fully to one lineage or the other or
stayed uncommitted. The stochastic simulations with various combinations of conflicting
ligand concentrations and for different levels of competitive inhibition show that all of
the populations obtained from the deterministic model are stable and distinct even with
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the introduction of noise. For conditions in which only one ligand was present (e.g.,
0|350), the cells committed only to the induced lineage for all levels of inhibition. A
small fraction of the initial population remained uncommitted for all conditions for the
chosen steady-state time point. When external cues of equal strength were provided
(175|175), cells in the absence of inhibition primarily reached the committed AB state;
with strong inhibition, they attained nearly equal levels of the committed A and B states;
and with moderate inhibition, the cells were roughly evenly distributed across the
bipotent, A, and B states. When high but unequal ligand levels were used (e.g., 100|250),
cells in the no inhibition model commit almost exclusively to the AB state since the
effects of LA and LB are entirely uncoupled. However for the strong and moderate
inhibition conditions, the initial population committed predominantly to the lineage
corresponding to the higher ligand value. This shows that, while the noise in the system is
capable of distributing the initial population to all available steady states for any ligand
concentration above a minimum threshold, a dominant external signal can still strongly
bias the system to its specific lineage.
5.3.5. Time trajectories during lineage commitment
From 100 individual stochastic trajectories, we calculated the average time for an
uncommitted cell to reach lineage A, lineage B, or the bipotent state and, in separate
simulations, the average time for a bipotent progenitor to reach lineage A or B. A phase
plot of the total transcription factors (tTF = ITF + ATF) shows that it takes ~36 hours for
the uncommitted cell to reach lineage A, lineage B, or the bipotent state; however, when
ligand concentrations that destabilize the bipotent progenitor are applied, it only takes
~24 hours for the bipotent progenitor to reach either of the committed states (Figure
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5.6A). This effect is even more pronounced when we look at the phase plots for ATF
(Figure 5.6B); the time to reach the high level of active transcription factor(s) from the
uncommitted cell is still ~36 hours, however it takes much less time (~14 hours) for the
bipotent progenitor to reach lineage A or B. The kinetics of reaching new steady-state
levels for total receptor (tR = R + C) and complex (Figures 5.6D and 5.6E) are faster than
those for tTF and ATF, respectively, but the trend of reaching commitment faster from
the bipotent state compared to the uncommitted state is similar to the transcription factor
plots. Figures 5.6C and 5.6F respectively show the mean CA and ATFA values with
respect to time (in hours) for transitions from the uncommitted state to lineage A (blue
line), uncommitted state to bipotent state (orange line), and bipotent state to lineage A
(green line). The error bars represent the standard deviation of the trajectories from the
mean values. The red lines show the decreases in CB and ATFB as the bipotent cell
follows the trajectory to commit to lineage A. A primed bipotent cell reaches either
committed state faster than an uncommitted cell does, primarily due to the fact that
accumulation of new transcription factor molecules (protein synthesis) is a much slower
process than deactivation of existing active transcription factor molecules. Furthermore,
cytokine signaling has been shown to accelerate differentiation, so the dynamics of
activated receptors and transcription factors are likely to influence the kinetics of
differentiation.
5.3.6. Comparison to experiments
Figure 5.7A shows a widely accepted branching diagram for differentiation from the
common myeloid progenitor (CMP). CMPs undergo lineage-restricted differentiation to
form either granulocyte-macrophage progenitors (GMPs) or megakaryocyte-erythrocyte
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progenitors (MEPs). GMPs give rise to neutrophils or macrophages, whereas MEPs
differentiate into megakaryocytes or erythrocytes. It has been recently demonstrated that
alternative routes of differentiation are possible in hematopoiesis: HSCs and multipotent
progenitors can bypass canonical intermediate states in reaching mature states, suggesting
that these lineage-restricting steps may be more complex than a series of simple binary
decisions. We have shown alternative trajectories analogous to these in Figure 5.7A (gray
arrows). In Figure 5.7B, the light green and light red lines represent 200 individual
stochastic trajectories from the strong inhibition model that committed to lineage A and
lineage B, respectively. The dark green and dark red lines show the average of these
trajectories. As the strong inhibition model cannot generate a bipotent state, all of the
trajectories are directed towards single-lineage populations (A or B). In Figure 5.7C, the
light blue, gray, and light red lines denote 200 individual stochastic trajectories from the
moderate inhibition model that committed to lineage A, the bipotent state, and lineage B,
respectively. The dark blue line denotes the average of all trajectories committing to
either lineage A or the bipotent state. The dark red line denotes the average of all
trajectories committing to either lineage B or the bipotent state.
To qualitatively compare the receptor dynamics predicted by our model to those
seen in experiments, we compared our simulations to lineage-specific receptor expression
from microarray data40 (graciously provided by Tariq Enver, University of Oxford); the
data were collected at multiple time points during differentiation of multipotent myeloid
progenitors (FDCP-mix, which are CMP-like progenitors) across three lineages
(neutrophil, erythrocyte, and megakaryocyte)40. The relative mRNA expression levels of
the lineage-specific receptors – erythropoietin receptor (EPOR), granulocyte colony147

stimulating factor receptor (GCSFR), and thrombopoietin receptor (TPOR) – were
extracted from the processed microarray data. Since the phenotypic heterogeneity was
also quantified at each time point in these microarray experiments, we were able to
perform a simple deconvolution to estimate the contribution of each distinct cell type to
the overall signal (see Table 5.4). Therefore, the receptor expression trajectory for a given
lineage in Figures 5.7D-F represents the average of only those multipotent, bipotent, and
committed cells that lie along that specific lineage path (as is also the case for the average
computational trajectories shown in bold lines in Figures 5.7B-C) and excludes those
cells that belong to other commitment paths (for example, the TPOR trajectory includes
blasts and megakaryocytes, but excludes erythroblasts, erythrocytes, and neutrophils
which were also present in the in vitro cultures used for microarray analysis). The level of
receptor was normalized to the basal levels in the CMP state. The error bars show the
standard error of the mean from three independent experiments.
We constructed phase plots of EPOR and GCSFR showing the receptor
trajectories (t = 0 to 7 days) as CMPs differentiate into either erythrocytes or neutrophils
(Figure 5.7D). Induction of CMPs with EPO or GCSF drives cell commitment to the
erythrocytic (red line) or the neutrophilic (green line) lineage, respectively. During
neutrophil commitment, GCSFR expression is significantly upregulated, but EPOR
expression stays at or below basal levels; conversely, during erythrocyte commitment,
EPOR expression is increased and GCSFR expression is unchanged or slightly reduced.
Figure 5.7E shows the experimental phase plot of TPOR and GCSFR expression when
CMPs are induced to differentiate into megakaryocyte or neutrophil lineages by
stimulating with TPO (blue line) and GCSF (green line), respectively. As in Figure 5.7D,
148

receptor expression corresponding to the induced lineage is upregulated and the receptor
expression corresponding to the other lineage is unchanged or even slightly
downregulated. Figure 5.7F shows the phase plot from the differentiation experiments to
erythrocytic and megakaryocytic lineages. Induction of CMPs with Epo or Tpo drives
CMPs to either the erythrocytic (red line) or the megakaryocytic (blue line) lineage.
Interestingly, during erythrocyte and megakaryocyte commitment, EPOR and TPOR are
co-upregulated; however, the observed increase was higher for the receptor
corresponding to the specific lineage that was predominantly generated. Statistical
analysis was performed to deduce positive receptor correlation for the receptor pairs in
Figures 5.7D, 5.7E, and 5.7F by comparing the overall slope of each trajectory (inverted
to lie along the x-axis, if appropriate) at both the 3-day and 7-day time points to a value
of zero (no correlation) by a one-sample, one-tailed t-test. The correlation in receptor
expression for EPOR-GCSFR and TPOR-GCSFR was either negative or not statistically
significant. However, the EPOR-TPOR receptor pair showed a positive correlation with
statistical significance. The symbols in Figure 5.7F denote the 3-day (†, *) and 7-day (‡,
#) time points during erythrocyte and megakaryocyte differentiation from the CMP (pvalues: † (0.027), * (0.009), ‡ (0.060), # (0.008)).
Comparing experimental results to the model simulations, we note that the
trajectories in the erythrocyte-neutrophil (Figure 5.7D) and neutrophil-megakaryocyte
(Figure 5.7E) plots compare well with the strong inhibition model (Figure 5.7B) and the
trajectories from the erythrocyte-megakaryocyte plot (Figure 5.7F) show agreement with
the moderate inhibition model (Figure 5.7C). This inference is validated by the widely
accepted observation that the transcription factors for the erythrocytic and
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megakaryocytic lineages are strongly cross-antagonistic to the transcription factor for the
neutrophil lineage. Other than evolutionary constraints, the model suggests that the
strength of the transcriptional cross-antagonism can dictate whether two distinct lineagespecific receptors (and the corresponding lineage-specific transcription factors) can be
co-upregulated, which in turn can influence the nature of the instructive, possibly
conflicting, cues that the cell receives. This paradigm may highlight different modes of
receptor regulation, and corresponding transcriptional activity, in various stages and
branches of hematopoiesis (e.g., Figure 5.7A).

5.4. Discussion
Mathematical models of lineage commitment during hematopoiesis have generally
analyzed cell-fate decisions from an intrinsic standpoint. Here, we show how extrinsic
regulation can play a role in instructing lineage choice and, furthermore, how a cell might
process and respond to conflicting extracellular cues. It has been extensively debated
whether cytokines play an instructive or permissive role during lineage commitment. In
this work, we have assumed that cell-fate decisions can be stochastic but that external
cues can strongly bias this stochasticity and instruct cells to specific lineages. A recent
publication definitively demonstrated an instructive role for cytokines in hematopoiesis20.
This strongly underscores our need to understand how extracellular cues, either in
isolation or in combination, influence hematopoiesis. Our model also suggests a possible
alternative mode of commitment, whereby an uncommitted multipotent progenitor may
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commit directly to a mature lineage without transitioning through a bipotent state. This
potential plasticity has been seen experimentally in HSCs4 and multipotent progenitors2.
The initial cell state that is modeled here is a common multipotent progenitor that
expresses multiple lineage-specific receptors and transcription factors at low levels and is
capable of differentiating along several lineages. In particular, two lineages that may
exhibit different levels of transcriptional cross-antagonism are analyzed. The lineage
commitment decision is modeled to be driven by the accumulation of the functionally
active form of the lineage-specific transcription factor. This event is driven through two
positive feedback loops, a synthesis loop that produces the transcription factor and a
regulatory loop that aids in the activation of the transcription factor. This two-step
positive feedback mechanism provides a means to externally regulate the classical
autofeedback loop and can be of general significance in cell-fate decision models. In our
lineage commitment model, the regulatory loop targets the cell-surface receptor, but
analogous topologies may be seen in systems where the regulation is achieved
extracellularly (upregulating the ligand) or intracellularly (upregulating a rate-limiting
enzyme in the signaling pathway). Also, it should be noted that even though we have
considered the external stimuli to be cytokines, they may also be cell-cell interactions,
cell-matrix interactions, mechanical cues, or other diffusible factors.
Through steady-state response plots, we have shown that the system exhibits
ultrasensitivity to ligand and can achieve multistability in active transcription factor
levels (Figure 5.4). Here, ultrasensitivity to ligand confers switch-like behavior in cellfate specification. Multistability provides memory to both the intermediate (bipotent) and
committed cell states, enabling the system to robustly sustain its current state even when
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external stimuli to sub-threshold levels after switching. Although the system modeled
here represents a reversible switch, irreversibility during differentiation can be achieved
by epigenetic means such as chromatin remodeling.
Hematopoiesis is traditionally viewed as a process in which a HSC undergoes
several lineage-restricted binary decisions to reach the mature state. However,
hematopoiesis may be more fluid than the classical paradigm suggests, as recent
experiments have shown that hematopoietic stem cells can completely bypass canonical
progenitor states during lineage commitment. While we acknowledge that the classical
view of lineage specification invokes binary decisions, it is possible that binary cell fatechoices are a special case of a more general decision-making strategy. For example, in
hematopoiesis, the common lymphoid progenitor appears to be oligopotent in producing
T cells, B cells, and NK cells without any observed bipotent intermediate. Our network
topology is capable of generating both binary and ternary cell-fate decisions, depending
on the strength of transcriptional cross-antagonism. For example, in Figure 5.5, strong
inhibition enables only a binary cell-fate choice; however, simply relaxing the strength of
the inhibition to moderate levels (without changing the topology) enables three possible
fates from the uncommitted state.
In support of the stochastic theory of commitment, our model suggests that,
irrespective of the strength of external factors, intrinsic noise in transcriptional networks
can switch a significant percentage of cells to a committed state or the bipotent state;
however, in support of the instructive theory, extrinsic cues can still strongly bias the
majority of the uncommitted cell population to the final state induced by the higher
ligand signal (e.g., see Figure 5.5). Our model suggests a new paradigm that integrates
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classical and alternative modes of lineage commitment and also accommodates both
stochastic and instructive roles in hematopoiesis (Figure 5.8). It is generally appreciated
that upstream commitment events are more stochastic in nature while downstream events
are more instructive. Stochastic events in HSCs and multipotent progenitors can
potentially lead to the generation of all mature cell types, explaining ‘normal’
hematopoiesis even when a lineage-specific receptor is knocked out (although other noncanonical extrinsic cues may also play compensatory roles). In parallel, instructive
cytokine signaling in multipotent progenitors and bipotent progenitors, which can
strongly bias and accelerate lineage commitment, may drive stress responses and restore
homeostasis. Furthermore, emerging alternative commitment paths suggest that decisionmaking in hematopoietic progenitors need not be purely binary. HSCs have been shown
to bypass multipotent progenitors and directly produce bipotent MEPs and common
lymphoid progenitors appear to directly generate T cells, B cells, and NK cells. The
model presented in this work suggests a framework in which both binary and ternary
decisions may be possible in multipotent CMPs. Such bypass mechanisms in
commitment may also provide important redundancies that ensure mature cell production
if a specific intermediate state becomes dysregulated.
Many of the predictions from our minimal, multipotent commitment model can be
experimentally verified. Multipotent and bipotent progenitors can be identified and sorted
with multi-color flow cytometry, using specific cell-surface markers for the lineages of
interest. Cytokine-induced time course experiments conducted on these bipotent cells can
corroborate whether they reach mature states faster than the corresponding multipotent
progenitors. Experiments with conflicting extracellular ligand cues can be useful in
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determining the strength of the instructive cues, the degree of transcriptional crossantagonism between lineages, and the existence of a bipotent progenitor. For example, to
analyze the differentiation paths of erythrocytes and neutrophils from a common
progenitor, FDCP-mix cells can be induced with both Epo and GCSF and the trajectories
of the expression of the lineage-specific transcription factors (GATA1, PU.1) and
receptors (EPOR, GCSFR) can be determined by sensitive flow cytometry measurements.
Furthermore, groundbreaking new bioimaging techniques which enable observation of
single cells over an extended period should mitigate technical difficulties that have
hampered such analyses and should help to further elucidate the roles of extrinsic and
intrinsic regulation on cell commitment decisions.
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Figure 5.1

Figure 5-1 A minimal model of multilineage commitment
A multipotent progenitor expresses lineage-specific receptors (RA and RB) and inactive
transcription factors (ITFA and ITFB) at low levels with the potential to differentiate into lineage
A or B. Addition of ligand (LA, LB) leads to complex formation (CA, CB), which activates the
corresponding lineage-specific transcription factor. Active TF (ATFA, ATFB) binds to the
response elements present upstream of the transcription factor and receptor genes and induces
two positive feedback loops (dashed green arrows). To account for cross-antagonism between the
lineages, the active transcription factors are modeled to competitively inhibit the activation of the
positive feedback loops in the other lineage (dashed red lines). F1A and F2A denote the respective
strengths of the transcription factor and receptor feedback loops for lineage A; similarly, F1B and
F2B represent the corresponding feedback strengths for lineage B. Inhibitor dissociation constants
KIA and KIB denote the inhibitory effect of A on B and B on A, respectively.
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Figure 5.2

Figure 5-2 Effect of the positive feedback loops on the on-state ATFA levels
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A. Strengths of the autofeedback loops (F1A and F1B) are varied for both lineages and the steadystate values of ATFA are plotted for the no inhibition condition (KIA = KIB = ∞), keeping the
strength of the receptor feedbacks (F2) constant. B. Strengths of the receptor feedback loops (F2A
and F2B) are varied and the values of ATFA are plotted for the no inhibition condition, keeping the
strength of the auto feedbacks (F1) constant. C. Same as part A except with moderate inhibition
(KIA = KIB = 400 molecules). D. Same as part B except with moderate inhibition. E. Crosssectional plot from C for various values of F1A. F. Cross-sectional plot from D for various values
of F2A. G. Same as part A except with strong inhibition (KIA = KIB = 50 molecules). H. Same as
part B except with strong inhibition. No inhibition and strong inhibition give rise to only on or off
populations, whereas moderate inhibition can generate a third intermediate population.
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Figure 5.3

Figure 5-3 Effect of the positive feedback loops on the on-state ATFB levels
Strengths of the autofeedback loops (F1A and F1B) are varied for both lineages and the steady-state
values of ATFB are plotted for no (A), moderate (C) and strong (E) inhibition, keeping the
strength of receptor feedback (F2A and F2B) constant. Strengths of the receptor feedback loops
(F2A and F2B) are varied and the values of ATFB are plotted for no (B), moderate (D) and strong
(F) inhibition, keeping the strength of autofeedback (F1A and F1B) constant.
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Figure 5.4

Figure 5-4 Effect of ligand on the on-state ATF levels
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A. Phase plot showing the steady-state ATFA levels (blue – low, yellow – medium, red – high)
when LA and LB values are varied. B. Phase plot showing the steady-state ATFB levels when LA
and LB values are varied. Low LA and low LB do not commit the uncommitted cell to either
lineage (overlapping blue region in A and B). Low LA and high LB values commit the cell to
lineage B (blue region in A and red region in B). High LA and low LB values commit the cell to
lineage A (red region in A and blue region in B). High LA and high LB commit the cell to the
bipotent state (overlapping yellow region in A and B). Steady-state response plots: C. Increasing
LA from 0, with LB constant at 300, abruptly switches the cell from the committed B state to the
bipotent state (increase in ATFA to intermediate level) after reaching a threshold concentration
(solid red line). After achieving the bipotent state, decreasing LA to sub-threshold values does not
immediately switch the cell state, suggesting significant memory in the system (dotted red line).
D. Increasing LA from 0, with LB constant at 300, decommits the cell to the bipotent state
(decrease in ATFB to intermediate level) after reaching the threshold concentration (solid blue
line). After achieving the bipotent state, decreasing LA to sub-threshold values does not
immediately switch the cell state, again suggesting significant memory (dotted blue line). E.
Increasing LA from 0, with LB constant at 100, abruptly switches the committed B cell to the
bipotent state (increase in ATFA to intermediate level) and then again to the committed A state
(increase in ATFA to high level) after reaching the corresponding threshold concentrations (solid
red line). After achieving the bipotent state or the committed state, decreasing LA to sub-threshold
values does not immediately switch the cell response, suggesting significant memory in both
states (dotted and dot-dash red line). F. Increasing LA from 0, with LB constant at 100, decommits
the cell to the bipotent state (decrease in ATFB to intermediate level) and then again to the
committed lineage A state (decrease in ATFB to low level) after reaching the corresponding
threshold concentrations (solid blue line). After achieving the bipotent state or the committed
lineage A state, decreasing LA to sub-threshold values does not immediately switch the cell
response, suggesting significant memory in both states (dotted and dot-dash blue line). Plots C
and D show bistable expression of ATFA and ATFB; plots E and F exhibit both bistable and
tristable expression of the transcription factors.
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Figure 5.5

LA = 0, LB = 350

LA = 100, LB = 250

LA = 175, LB = 175

Figure 5-5 External regulation of stochastic transitions
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Three different LA|LB combinations (0|350, 100|250, and 175|175) were run using the stochastic
version of the model with no, moderate, or strong inhibition conditions and the system was
allowed to reach steady state. ATFA and ATFB values from 10,000 runs for each condition are
plotted here as three-dimensional histograms. With strong inhibition, the system cannot achieve
the intermediate, bipotent state that is seen with moderate inhibition. When induced with only one
ligand (e.g., 0|350), the initial population, for all inhibition conditions, commits predominantly to
the lineage corresponding to that ligand. When the uncommitted state is stimulated with equal
values of ligand (175|175), the no inhibition condition primarily results in a state that corresponds
to high activation of both transcription factors (unlikely to be a biologically relevant state for cellcommitment decisions); the strong and the moderate inhibition conditions result in significant
population of all of the available states except the uncommitted state. When one ligand value is
higher (e.g., 100|250), in the presence of inhibition, the majority of the cells committed to the
lineage corresponding to the higher ligand concentration. The number next to each individual
population denotes the percentage of the total population when treated with the given
combination of LA and LB.
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Figure 5.6

Figure 5-6 Time trajectories during lineage commitment
A. Phase plot of total transcription factor (ITF+ATF) for the four steady-state populations
(uncommitted, A, B, and bipotent). B. Phase plot of active transcription factor (ATF). C. Time
trajectories for ATFA in panel B for the transition from the uncommitted cell to committed A state
(blue line) and bipotent state (orange line) and from the bipotent state to committed A state (green
line) is shown as a time course plot. The error bars represent the standard deviation of the mean.
The red line shows the level of ATFB as the bipotent cell transitions to the committed A state. D.
Phase plot of total receptor (R+C). E. Phase plot of active complex (C). F. Time trajectories for
CA in panel E for the transition from the uncommitted cell to committed A state (blue line) and
bipotent state (orange line) and from the bipotent state to committed A state (green line) is shown
as a time course plot. The error bars represent the standard deviation of the mean. The red line
shows the level of CB as the bipotent cell transitions to the committed A state. In the phase plots,
the arrows indicate the direction of commitment (averaged over 200 stochastic runs each): from
the uncommitted state, the three possible commitment trajectories lead to pure lineage A, pure
lineage B, and the bipotent state. In separate simulations starting with the bipotent state and with
initial ligand concentrations sufficient to destabilize this state, the two possible commitment
trajectories lead to pure lineage A and pure lineage B. Each trajectory has several nodes and the
number at each node denotes the average time (in hours) it takes to reach the node from the initial
state. Each black dot in A, B, D and E represents the endpoint (100,000 min) of an individual
stochastic trajectory.
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Figure 5.7

Figure 5-7 Comparison of multilineage commitment model to experimental data
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A. The classical model of hematopoiesis is given here as a branching diagram showing the
differentiation paths from the common myeloid progenitor (CMP) to four distinct myeloid
lineages (megakaryocyte, erythrocyte, neutrophil, and macrophage) via bipotent progenitors
(GMP – granulocyte/macrophage progenitor and MEP – megakaryocyte/erythrocyte progenitor).
Other possible alternate routes of commitment, bypassing the bipotent state, are shown as gray
lines. B. Stochastic simulations of total receptor levels under strong competitive inhibition. Light
green and red lines indicate the individual trajectories from the uncommitted cell to lineages A
and B, respectively. The dark red and green lines denote the averaged trajectories of all stochastic
runs. C. Stochastic simulation for total receptor levels under moderate competitive inhibition
condition. Light blue, light red, and gray lines indicate the individual trajectories from the
uncommitted cell to A, B, and the bipotent state, respectively. The dark blue line denotes the
average value of all stochastic runs that commit to either lineage A or the bipotent state; the dark
red line denotes the average value of all stochastic runs that commit to either lineage B or the
bipotent state. D. Trajectories from microarray data showing upregulation of EPOR and GCSFR
during erythrocyte (red) and neutrophil (green) commitment from the CMP, respectively. E.
Trajectories from microarray data showing upregulation of TPOR and GCSFR during
megakaryocyte (blue) and neutrophil (green) commitment from the CMP, respectively. F.
Trajectories from microarray data showing upregulation of EPOR and TPOR during erythrocyte
(red) and megakaryocyte (blue) commitment from the CMP. The data in D-F represent the
average of the multipotent, bipotent, and mature cells for any single lineage (see Table S4), thus
enabling a direct comparison to the model simulations. The error bars in D-F show the standard
error of the mean. The symbols in F denote the 3-day (†, *) and 7-day (‡, #) time points during
erythrocyte and megakaryocyte differentiation from the CMP, respectively. Statistical analysis
was performed to deduce positive correlation in receptor pair upregulation by comparing the
overall slope of each trajectory (inverted to lie along the x-axis, if appropriate) at both the 3-day
and 7-day time points to a value of zero (no correlation) by a one-sample, one-tailed t-test (pvalues: † (0.027), * (0.009), ‡ (0.060), # (0.008)).
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Figure 5.8

Figure 5-8 Proposed paradigm for hematopoiesis
Extrinsic (instructive) and intrinsic (stochastic) cues can both play roles in commitment of
progenitor cells. In addition to classical pathways of commitment (solid arrows), bypass
mechanisms have been reported for HSCs (dashed green arrow) and our model suggests that this
may be possible for multipotent progenitors as well (dashed purple arrow).
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Table 5.1
Table 5-1 Ordinary differential equations for the deterministic model
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Table 5.2
Table 5-2 Rate constants and initial conditions for the deterministic and stochastic models
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Table 5.3
Table 5-3 Probability functions and reactions for the stochastic model
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Table 5.4
Table 5-4 Parameter fitting of microarray data
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